Contact hearing device and retention structure materials

Information

  • Patent Grant
  • 11516603
  • Patent Number
    11,516,603
  • Date Filed
    Monday, August 31, 2020
    4 years ago
  • Date Issued
    Tuesday, November 29, 2022
    2 years ago
Abstract
Hearing aid devices, methods of manufacture, methods of use, and kits are provided. In certain aspects, the hearing aid devices comprise an apparatus having a transducer and a retention structure comprising a shape profile corresponding to a tissue of the user, and a layer of elastomer.
Description
BACKGROUND OF THE INVENTION
Field of the Invention

The present invention relates to the use of select materials in the sulcus and umbo platform of a contact hearing aid device and, more particularly, to the use of materials having specific characteristics which improve the performance of the contact hearing aid devices.


Background

A contact hearing system is a system including a contact hearing device, an ear tip and an audio processor. Contact hearing systems may also include an external communication device. An example of such system is an Earlens hearing-aid. In the Earlens system, audio is received by an audio processor and transmitted by laser to a contact hearing device which is placed on the ear drum of a user.


A contact hearing device, which may also be referred to as a tympanic contact actuator or tympanic lens, includes a tiny actuator connected to a customized ring-shaped support platform that floats on the ear canal around the eardrum. The contact hearing device resides in the ear much like a contact lens resides on the surface of the eye. In a contact hearing device, an actuator directly vibrates the eardrum which causes energy to be transmitted through the middle and inner ears to stimulate the brain and produce the perception of sound. The contact hearing device may comprise a photodetector, a microactuator connected to the photodetector, and a support structure supporting the photodetector and microactuator. The contact hearing device may comprise a photodetector, a transducer connected to the photodetector, and a support structure for supporting the photodetector and the transducer. The contact hearing device may comprise a receive coil, a microactuator connected to the receive coil, and a support structure supporting the receive coil and microactuator. The contact hearing device may comprise a receive coil, a transducer connected to the receive coil, and a support structure supporting the receive coil and transducer. In alternate embodiments, the contact hearing device may include one or more coils and one or more antennas.


The Earlens contact hearing device is secured in the ear canal by using a perimeter platform, which may also be referred to as a sulcus platform, made out of a thin film of Parylene™ C. In this design, the perimeter platform surrounds the transducer and supports its position within the ear canal. In U.S. Pat. No. 9,392,377 to Olsen et al., this perimeter platform is described as being made from poly(para-xylylene) (Parylene™-N), or variants thereof, such as poly(chloro-p-xylene) (Parylene™ C), poly(p-xylene), poly(dichloro-p-xylene) (Parylene™ D), or fluorinated poly(p-xylene) (Parylene™ F). However, when a contact hearing device including a perimeter platform made from any of those materials is delivered through the ear canal it may be difficult to avoid deforming or wrinkling the Parylene™. Such wrinkles may result in permanent deformation of the intended perimeter platform geometry, and may therefore reduce the ability of the perimeter platform and, thus, the contact hearing device to resist displacement. When a displacement occurs, the contact hearing device moves from its optimal position adjacent the tympanic membrane to anew position. Movement of the contact hearing device to a new position may result in deterioration of the performance of the hearing aid. It has been observed clinically that there is a strong correlation between wrinkling of the material making up the perimeter platform and displacement, resulting in unacceptable hearing aid performance when wrinkles are present.


In a contact hearing system, a microactuator may be placed on a subject's tympanic membrane (ear drum) such that the microactuator vibrates the tympanic membrane in response to an external signal. Generally, the external signal is an acoustic signal which is converted to an electronic signal in a signal processor which forms a part of the contact hearing aid system. The electronic signal may then be converted to an optical signal. The optical signal may be transmitted to a photodetector which then converts the optical signal to mechanical motion by means of the microactuator. However, to insure optimum signal transduction between the microactuator and the tympanic membrane, the microactuator must remain in close proximity to its designed position. In the prior art system, the microactuator may be secured in position using a perimeter platform made of Parylene™ or a Parylene™ variant, such as, Parylene™ C.


One of the limitations of Parylene™ as a perimeter platform is that, once it is deformed it does not completely recover from that deformation. Deformation may occur under a number of circumstances, such as when the contact hearing device is delivered through a subject's ear canal to the tympanic membrane. Once the Parylene™ platform is deformed, it does not return to its pre-deformation shape and the resulting geometry of the perimeter platform is therefore different from the anatomy of the subject. If the perimeter platform is deformed and no longer conforms to the anatomy of the user, the contact hearing device may be more likely to become displaced from its intended position. When a contact hearing device becomes displaced, signal transduction may be impeded, resulting in reduced hearing improvement.


A perimeter platform may also be designed to ensure that the platform does not cause injury to tissues in the ear through the application of excessive pressure. Thus, the perimeter platforms may be designed to apply a slight pressure to surrounding tissue when it is placed in the ear. In particular, with the perimeter platform in place, capillaries in the surrounding tissue remain capable of re-filling with blood during each cardiac cycle. In general, the perimeter platform would be designed to apply a pressure of less than about 20 mm Hg. In order to meet this requirement, the hardness and geometry of the perimeter platform may be controlled so that it does not impose significant pressure upon the tissue.


A perimeter platform may also be made from materials which do not degrade or lose function after prolonged periods in the ear canal. Such materials would preferably be biocompatible, including meeting preset requirements for cytotoxicity, irritation and sensitization.


A perimeter platform may also be made from materials which do not swell substantially or gain weight after prolonged periods in an ear canal. Prolonged periods in an ear canal should not cause significant dimensional changes in materials used in a perimeter platform as such dimensional changes (e.g., changes in material thickness or weight) may have detrimental consequences, leading to, for example, displacement of the contact hearing device. Dimensional stability is particularly important because a precise fit is required to insure that the contact hearing device remains in its position on the ear.


SUMMARY OF THE INVENTION

The present disclosure provides apparatus having a transducer and a retention structure comprising a shape profile corresponding to a tissue of a user, and a layer of elastomer. The disclosure also provides alternate apparatus, methods of manufacture, methods of use, and kits.


This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This summary is not intended to identify key features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.


In various aspects, the present disclosure provides an apparatus for placement with a user, the apparatus comprising: a transducer; and a retention structure comprising: a shape profile corresponding to a tissue of the user to couple the transducer to the user, wherein the retention structure maintains a location of the transducer when coupled to the user; and a layer of elastomer, wherein the elastomer has a hardness of between 0 A and 100 A, and a thickness of between approximately 25 microns and approximately 500 microns.


In some aspects, the elastomer has a Young's modulus of between 0.5 MPa and 50 MPa. In some aspects, the elastomer has a hardness of between approximately 25 A and approximately 95 A. In some aspects, the elastomer has an ultimate tensile strength of between 0.5 MPa and 5.0 MPa, or the elastomer has an ultimate tensile strength of between 5 MPa and 50 MPa. In some aspects, the layer of elastomer has a thickness of between approximately 25 microns and approximately 500 microns. In some aspects, the elastomer has an ultimate tensile strength of between approximately 1 MPa and approximately 300 MPa, between approximately 20 MPa and approximately 100 MPa, or between approximately 40 MPa and approximately 60 MPa at an elongation of approximately 650%. In some aspects, the elastomer has a tensile stress of between approximately 2.0 MPa and approximately 4.0 MPa at 50% elongation. In some aspects, the elastomer has a tensile stress of between approximately 3.0 MPa and approximately 5.0 MPa at 100% elongation.


In some aspects, the layer of elastomer has a change in Young's Modulus of less than 15%, less than 50%, or less than 75%, compared to a reference layer of elastomer following exposure to a test bath for 16 days at 37° C., the test bath comprising 10 wt % Synthetic Cerumen, 10 wt % EN1811 Sweat, and 80 wt % mineral oil. In some aspects, the layer of elastomer has a change in weight of less than 30% compared to a reference layer of elastomer, following exposure to a test bath for 16 days at 37° C., the test bath comprising 10 wt % Synthetic Cerumen, 10 wt % EN1811 Sweat, and 80 wt % mineral oil. In some aspects, the layer of elastomer has a change in wall thickness of less than 15% compared to a reference layer of elastomer, following exposure to a test bath for 16 days at 37° C., the test bath comprising 10 wt % Synthetic Cerumen, 10 wt % EN1811 Sweat, and 80 wt % mineral oil.


In some aspects, the layer of elastomer further comprises between approximately 5% and approximately 15% polydimethylsiloxane by weight, or wherein the platform material comprises between approximately 9% and approximately 11% polydimethylsiloxane by weight. In some aspects, the layer of elastomer comprises a polyurethane, a polycarbonate urethane with a silicone rubber soft segment, a polycarbonate urethane, an aromatic polyurethane, a fluoropolymer, a polyetherurethane, a nylon, a polyetherblockamide, an aliphatic polyetherurethane, a propylene, a propylene with rubber, or any combination thereof. In some aspects, the layer of elastomer comprises a polycarbonate-based silicone elastomer, a polycarbonate urethane with poly(dimethylsiloxane) soft segment, a fluoropolymer, THV [poly(tetrafluoroethylene-co-hexafluoropropylene-co-vinylidene fluoride)], a polycarbonate urethane-co-poly(dimethyl siloxane), any derivative thereof, or any combination thereof. In some aspects, the layer of elastomer comprises one or more of aliphatic polycarbonate-based thermoplastic urethane, polycarbonate urethane with poly(dimethyl siloxane) soft segment, and polycarbonate urethane-co-poly(dimethyl siloxane).


In some aspects, the retention structure comprises a curved portion having an inner surface toward an eardrum of the patient when placed, and wherein the curved portion couples to an ear canal wall of the patient, oriented toward the eardrum when placed to couple the transducer to the eardrum. In some aspects, the curved portion couples to the ear canal on a first side of the ear canal opposite the eardrum, and wherein a second portion of the retention structure couples to a second side of the ear canal opposite the first side to hold the retention structure in the ear canal. In some aspects, the curved portion and the second portion are connected so as to define an aperture extending therebetween to view at least a portion of the eardrum when the curved portion couples to the first side of the ear canal and the second portion couples to the second side.


In some aspects, the retention structure includes ridges along a tissue facing surface. In some aspects, the ridges are formed as part of a three dimensional printing process. In some aspects, the three dimensionally printed component is a mold used to form the layer of elastomer.


In some aspects, the layer of elastomer has a surface air-water contact angle of between approximately 100 degrees and approximately 130 degrees, or wherein the layer of elastomer has a surface air-water contact angle of between approximately 115 degrees and approximately 125 degrees, or wherein the layer of elastomer has a surface air-water contact angle of between approximately 20 degrees and approximately 80 degrees.


In some aspects, the apparatus further comprises an umbo platform, wherein the umbo platform comprises one or more of polycarbonate urethane with poly(dimethyl siloxane) soft segment or polycarbonate urethane-co-poly(dimethyl siloxane). In some aspects, the apparatus further comprises a coating polymer, the coating polymer comprising a poly(p-xylylene) polymer. In some aspects, the elastomer has a hardness of between 65 A and 100 A


In various aspects, the present disclosure provides a method of treating a user in need of a hearing device, the method comprising: providing the user with an apparatus for placement with a user, the apparatus comprising: a transducer; and a retention structure comprising: a shape profile corresponding to a tissue of the user to couple the transducer to the user, wherein the retention structure maintains a location of the transducer when coupled to the user; and a layer of elastomer, wherein the elastomer has a hardness of between 0 A and 100 A, and a thickness of between approximately 25 microns and approximately 500 microns; and inserting the apparatus into an ear of the user, such that the transducer is in proximity to the eardrum of the user. In some aspects, the method further comprises the step of administering mineral oil to the apparatus, to the ear of the user, or any combination thereof.


In various aspects, the present disclosure provides a kit, the kit comprising: an apparatus for placement with a user, the apparatus comprising: a transducer; and a retention structure comprising: a shape profile corresponding to a tissue of the user to couple the transducer to the user, wherein the retention structure maintains a location of the transducer when coupled to the user; and a layer of elastomer, wherein the elastomer has a hardness of between 0 A and 100 A, and a thickness of between approximately 25 microns and approximately 500 microns; and instructions for use of the apparatus. In some aspects, the kit further comprises mineral oil.


In various aspects, the present disclosure provides a method of manufacturing an apparatus for placement with a user, the apparatus comprising: a transducer; and a retention structure comprising: a shape profile corresponding to a tissue of the user to couple the transducer to the user, wherein the retention structure maintains a location of the transducer when coupled to the user; and a layer of elastomer, wherein the elastomer has a hardness of between 0 A and 100 A, and a thickness of between approximately 25 microns and approximately 500 microns, the method comprising an injection molding process.


In various aspects, the present disclosure provides a method of manufacturing an apparatus for placement with a user, the apparatus comprising: a transducer; and a retention structure comprising: a shape profile corresponding to a tissue of the user to couple the transducer to the user, wherein the retention structure maintains a location of the transducer when coupled to the user; and a layer of elastomer, wherein the elastomer has a hardness of between 0 A and 100 A, and a thickness of between approximately 25 microns and approximately 500 microns, the method comprising a solvent coating process.


In various aspects, the present disclosure provides a method of manufacturing an apparatus for placement with a user, the apparatus comprising: a transducer; and a retention structure comprising: a shape profile corresponding to a tissue of the user to couple the transducer to the user, wherein the retention structure maintains a location of the transducer when coupled to the user; and a layer of elastomer, wherein the elastomer has a hardness of between 0 A and 100 A, and a thickness of between approximately 25 microns and approximately 500 microns, the method comprising a 3D printing process.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing and other objects, features and advantages of embodiments of the present inventive concepts will be apparent from the more particular description of preferred embodiments, as illustrated in the accompanying drawings in which like reference characters refer to the same or like elements. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the preferred embodiments.



FIG. 1 is a top view of a contact hearing device according to the present invention.



FIG. 2 is a bottom view of a contact hearing device according to the present invention.



FIG. 3 is a side view of a contact hearing device according to the present invention.



FIG. 4 is an exploded top view of a contact hearing device according to the present invention.



FIG. 5 is a side view of a contact hearing device according to the present invention with the contact hearing device positioned on the tympanic membrane of a user.



FIG. 6 is a bottom view of a contact hearing device including ridges according to the present invention.



FIG. 7 is a chart displaying example tensile stress-strain curves for material samples.





DETAILED DESCRIPTION OF THE INVENTION

In some embodiments, the present invention discloses an apparatus for placement with a user. In certain embodiments, the apparatus comprises a transducer and a retention structure, wherein the retention structure comprises a shape profile and a platform material, wherein the retention structure comprises a resilient retention structure to maintain a location of the transducer when coupled to the user, wherein the platform material has a thickness to resist deflection away from the shape profile, and wherein the platform material comprises the shape profile in an unloaded configuration. In some embodiments, the platform material comprises a layer of elastomer. In certain embodiments, the apparatus comprises a transducer and a retention structure, wherein the retention structure comprises a layer of elastomer, and wherein the layer of elastomer has a shape profile, wherein the retention structure comprises a resilient retention structure to maintain a location of the transducer when coupled to the user, wherein the elastomer has a thickness to resist deflection away from the shape profile, and wherein the elastomer comprises the shape profile in an unloaded configuration. In some embodiments, the elastomer may be coated with a coating polymer, such as a poly(p-xylylene) polymer (e.g., a Parylene™) or derivative thereof.


In some embodiments, the elastomer has a shape profile corresponding to a tissue of the user to couple the transducer to the user. As a non-limiting example, the retention structure can comprise a shape profile corresponding with the ear canal of the user, the concha of the user, the umbo of the user, the antihelix of the user, the tringular fossa of the user, the external auditory meatus of the user, the tragus of the user, the antitragus of the user, the scapha of the user, or any combination thereof. In some embodiments, the substrate has a shape profile corresponding to the tissue of the user. In some embodiments, the substrate has a shape profile corresponding to the ear canal tissue of a user. In certain embodiments, at least a portion of the substrate has a shape profile corresponding to the sulcus region of the ear canal of a user.


In some embodiments, the retention structure comprises a curved portion having an inner surface toward an eardrum of the patient when placed. In some embodiments, the retention structure comprises a curved portion having an inner surface directed toward the eardrum of the patient when placed onto the patient's ear. In some embodiments, the curved portion couples to an ear canal wall and is oriented toward the eardrum when placed. In some embodiments, the apparatus further comprises a transducer. In some embodiments, the transducer comprises an actuator. In certain embodiments, the actuator is a microactuator. In certain embodiments, the transducer comprises a microactuator, such as a balanced armature microactuator. In some embodiments, the transducer comprises a piezoelectric transducer. In certain embodiments, the transducer is a piezoelectric transducer. In certain embodiments, the apparatus is placed to couple the actuator to the eardrum. In some embodiments, the curved portion of the apparatus couples to the ear canal on a first side of the ear canal opposite the eardrum, and a second portion of the retention structure couples to a second side of the ear canal opposite the first side to hold the retention structure in the ear canal. In some embodiments, the curved portion of the apparatus and the second portion are connected so as to define an aperture extending therebetween. In some embodiments, the curved portion couples to the first side of the ear canal and the second portion couples to the second side.


In some embodiments, the apparatus comprises an output transducer assembly comprising a transducer. The output transducer assembly may be configured for placement in the medial ear canal, and is also referred to as a medial ear canal assembly. The output transducer assembly can receive a sound input, for example an audio sound or an input from an external communication device. With hearing aids for hearing impaired individuals, the input can be ambient sound. The external communication device may comprise at least one input transducer, for example a microphone. The at least one input transducer may comprise a second microphone located away from the first microphone, in the ear canal or the ear canal opening, for example positioned on a sound processor. The at least one input transducer assembly may also include a suitable amplifier or other electronic interface. In some embodiments, the input may comprise an electronic sound signal from a sound producing or receiving device, such as a telephone, a cellular telephone, a Bluetooth connection, a ratio, a digital audio unit, and the like.


In some embodiments of the invention, the output transducer assembly comprises a transducer, a photodetector, a spring, a support structure, and a retention structure.


In some embodiments of the invention, the output transducer assembly is adapted to receive the output form the input transducer assembly and produce mechanical vibrations in response to the received information, which may be, for example, in the form of a light signal generated by a lateral ear canal assembly. In some embodiments of the invention, the medial ear canal assembly or output transducer assembly comprises a sound transducer, wherein the sound transducer may comprise at least one of a microactuator, a coil, a magnet, a magnetostrictive element, a photostrictive element, or a piezoelectric element. In some embodiments of the invention, the input transducer assembly may comprise alight source coupled to sound processor by a fiber optic cable and positioned on a lateral ear canal assembly. In some embodiments of the invention, the input transducer assembly may comprise a laser diode coupled to a sound processor and positioned on the lateral ear canal assembly. In some embodiments of the invention, the light source of the input transducer assembly may be positioned in the ear canal along with a sound processor and a microphone. When properly coupled to the subject's hearing transduction pathway, the mechanical vibrations caused by the apparatus can stimulate the cochlea CO, which induces neural impulses in the subject which can be interpreted by the subject as a sound input.


In some embodiments, the platform material comprises the shape profile when in an unloaded configuration. In some embodiments, the elastomer comprises the shape profile when in an unloaded configuration. The apparatus is in an unloaded configuration when it is not coupled to the user (e.g., prior to insertion into the ear).


In some embodiments, the retention structure comprises a resilient retention structure, which will maintain the location of the actuator when coupled to the user. As a non-limiting example, the retention structure can maintain the actuator in proximity to the ear drum of the user. In certain embodiments, the retention structure maintains the actuator closer than 1 mm, closer than 2 mm, closer than 3 mm, closer than 4 mm, closer than 5 mm, closer than 6 mm, closer than 7 mm, closer than 8 mm, closer than 9 mm, closer than 10 mm, closer than 2 cm, or closer than 3 cm from the ear drum of the user. In certain embodiments, the structure can maintain the location of the actuator by the shape of the retention structure, as well as the composition of the layer of elastomer. In some embodiments, the elastomer can resist deflection away from the shape profile. In some embodiments, the retention structure can maintain the transducer in proximity to the tympanic membrane of the user.


In some embodiments, the user is a patient in need of a contact hearing apparatus. In some embodiments, the user is a mammal. In certain embodiments, the user is a human. In certain embodiments, the user is a patient suffering from hearing loss.



FIG. 1 is atop view of a contact hearing device 100 (which may also be referred to as a tympanic lens, output transducer assembly, or medial ear canal assembly) according to the present invention. FIG. 2 is a bottom view of a contact hearing device 100 according to the present invention. FIG. 3 is a side view of a contact hearing device 100 according to the present invention. FIG. 4 is an exploded top view of a contact hearing device 100 according to the present invention. In the contact hearing device of FIGS. 1, 2, 3, and 4, a perimeter platform 155 is mounted on a chassis 170. Perimeter platform 155 may include a sulcus platform 150 at one end of perimeter platform 155. Chassis 170 may further include bias springs 180 (which may also be referred to as torsion springs) mounted thereon and supporting transducer 140. Transducer 140 is connected to drive post 200, which is connected to umbo lens 240 by adhesive 210. Chassis 170 further supports grasping tab 190 and photodetector 130. In some embodiments of the invention, signals may be transmitted to contact hearing device 100 by, for example, magnetic coupling or radio frequency transmission. In some embodiments of the invention, element 130 may be a receiving coil or an antenna.



FIG. 5 is a further side view of a contact hearing device 100 according to the present invention where in contact hearing device 100 is positioned on the tympanic membrane TM of a user. In FIG. 5, contact hearing device 100 comprises perimeter platform 155 which includes sulcus platform 150 at one end thereof. Perimeter platform 155 is connected to chassis 170, which supports transducer 140 through bias springs 180. Transducer 140 includes transducer reed 350 extending from a distal end thereof. Transducer reed 350 is connected to umbo lens 220 through drive post 200. Chassis 170 further supports photodetector 130, which is electrically connected to transducer 140. In FIG. 5, perimeter platform 155 is positioned on skin SK covering the boney portion BN of the ear canal EC. The sulcus platform portion 150 of perimeter platform 155 is positioned at the medial end of the ear canal in the tympanic annulus TA. Umbo lens 200 is positioned on umbo UM of tympanic membrane TM. In FIG. 5, an oil layer 225, of, for example, mineral oil may be positioned between perimeter platform 155 and skin SK and between umbo lens 220 and umbo UM.



FIG. 6 is a bottom view of a contact hearing device including ridges 360 according to the present invention. In some embodiments of the invention, the platform may retain 3D printing ridges 360, which may be, for example, used as a quality check to ensure that the platform conformed exactly to the mold. In some embodiments of the invention, the ridges may be formed when the elastomer comes into contact with the surface of the mold, where the mold is manufactured using three dimensional printing techniques. In some embodiments, the apparatus can comprise ridges along a tissue-facing surface. In certain embodiments, the apparatus comprises a elastomer comprising ridges along the tissue facing surface. In certain embodiments, the ridges are formed as a part of a three-dimensional (3D) printing process. In specific embodiments, the 3D printed component is a mold used to form the retention structure.


In order to resolve the issues described in the Background, it would be desirable to manufacture the retention platform out of a material that can recover its shape after deformation, such as the deformation experienced during delivery of a contact hearing device through an ear canal, while meeting all of the other requirements of a suitable platform material. In some embodiments, the platform material comprises a layer of elastomer. In certain embodiments, the platform material is a layer of elastomer. Elastomers represent a class of materials which can experience significant strain (often >50%) and recover their original shape once the deformation force has been relieved. In some embodiments of the invention, the use of elastomers in a retention platform for a contact hearing device may improve the stability of the contact hearing device in the ear canal. In some embodiments, the apparatus can comprise a layer of elastomer and additional layers of material. In certain embodiments, the apparatus can comprise a plurality of layers of elastomer.


In addition to the other requirements described herein, a suitable layer of elastomer according to the present invention would be a material which was optimized for one or more of the following characteristics: biocompatibility, dimensional stability, tensile modulus, surface structure and material thickness.


A suitable platform material would meet biocompatibility requirements which would ensure that it could be used in the ear of a user and, more particularly, could be placed in the ear canal of a user for an extended period of time without irritating or damaging the ear canal or components of the ear canal, including the tissue lining the ear canal. In some embodiments of the invention, suitable biocompatibility would include meeting requirements for measurements of cytotoxicity, sensitization and irritation. Such requirements may include requirements established by the International Organization for Standardization (“ISO”). In some embodiments of the invention, a suitable platform material would be expected to meet the cytotoxicity requirements of ISO 10993-5. In some embodiments of the invention, a suitable platform material would be expected to meet the sensitization requirements of ISO 10993-10. In some embodiments of the invention, a suitable platform material would be expected to meet the irritation requirements of ISO 10993-10. In some embodiments, the apparatus comprises a layer of elastomer that meets the cytotoxicity requirements of ISO 10993-5, the sensitization requirements of ISO 10993-10, and the irritation requirements of ISO-10993-10.


In some embodiments of the invention, a suitable elastomer would meet dimensional stability requirements which would ensure that key characteristics of the material would not change significantly when placed into an environment such as the ear canal of a user. In particular, the dimensional and stability requirements ensure that interaction between fluids found in the ear canal and the material would not change the key characteristics of the material in a way that detrimentally effects its performance when used in a contact hearing device, including, for example, as a sulcus or umbo platform material in a contact hearing device. Fluids which might be present in the ear canal include both physiological fluids, such as sweat or cerumen and externally introduced fluids such as mineral oil. In some embodiments of the invention, the dimensional stability of the material may be measured by comparing the raw material to material that has been soaked in a bath having a predetermined composition and measuring changes to the material after it is removed from the bath. In one embodiment of the invention, a suitable test bath may comprise a mixture of approximately 80% mineral oil, approximately 10% natural or artificial sweat and approximately 10% natural or artificial cerumen. In some embodiments of the invention, materials may be left in the test bath for a predetermined period of time. In some embodiments of the invention, materials may be left in the test bath for between sixteen (16) and thirty (30) days. In some embodiments of the invention, the test bath may be held at a predetermined temperature. In some embodiments of the invention, the test bath may be held at a temperature of between approximately 35 and approximately 39 degrees centigrade. In some embodiments of the invention, the test bath may be held at a temperature of approximately 37 degrees centigrade. The bath may separate into one or more phases since the mineral oil and cerumen phases may be immiscible with the artificial sweat phase. In some embodiments, the solution is stirred to form an emulsion. The stirring may be performed at various rates depending on the volume of the fluid test bath. In some embodiments, the stir rate is in the range from 0 to 1000 rpm, from 25 to 800 rpm, from 50 to 600 rpm, from 75 to 500 rpm, from 100 to 450 rpm, from 150 to 400 rpm, from 200 to 375 rpm, or from 250 to 350 rpm. In some embodiments, the stir rate is greater than 1 rpm, greater than 20 rpm, greater than 40 rpm, greater than 60 rpm, greater than 80 rpm, greater than 100 rpm, greater than 200 rpm, greater than 300 rpm, greater than 400 rpm, greater than 500 rpm, greater than 600 rpm, greater than 700 rpm, greater than 800 rpm, greater than 900 rpm, or greater than 1000 rpm.


Some of the key characteristics that might be expected to change when the layer of elastomer is placed into a test bath and/or into the ear canal of a user include changes to the dimensions of the platform resulting from, for example, the absorption of fluids from the ear canal. In some embodiments of the invention, such dimensional changes may include changes in the thickness of the materials, changes in the weight of the materials or changes in the tensile modulus of the materials. In certain embodiments, changes to the layer of elastomer are compared by exposing said material to a suitable test bath, comprising a mixture of approximately 80% mineral oil, approximately 10% natural or artificial sweat, and approximately 10% natural or artificial cerumen. In some embodiments, the layer of elastomer comprises material in the form of extruded tubing. The parameters (e.g., change in weight, thickness, or tensile modulus of the layer of elastomer) after said material has been left in the test bath for up to sixteen (16) days, the test bath being held at a temperature of approximately 37 degrees centigrade. The changes are compared against a reference layer of elastomer that is not subjected to the test bath.


In some embodiments of the invention, an apparatus comprising the layer of elastomer that is placed into a test bath and/or into the ear canal of a user can have a change in wall thickness. In some embodiments, the wall thickness changes would be approximately 0%. In some embodiments of the invention, wall thickness changes would be between approximately 0% and 0.5%, between approximately 0% and 1%, between approximately 0% and 2%, between approximately 0% and 3%, between approximately 0% and 4%, between approximately 0% and 5%, between approximately 0% and 6%, between approximately 0% and 7%, between approximately 0% and 8%, between approximately 0% and 9%, between approximately 0% and 10%, between approximately 0% and 15%, or between approximately 0% and 20%. In some embodiments of the invention, wall thickness changes would be less than 0.5%, less than 1%, less than 2%, less than 3%, less than 4%, less than 5%, less than 6%, less than 7%, less than 8%, less than 9%, less than 10%, less than 15%, or less than 20%.


In some embodiments of the invention, an apparatus comprising the layer of elastomer that is placed into a test bath and/or into the ear canal of a user can have a change in weight. In some embodiments of the invention, weight change is approximately 0% from the weight of a comparable apparatus that is not placed into a test bath and/or into the ear canal of a user. In some embodiments of the invention, weight change would be between approximately 0% and 0.5%, between approximately 0% and 1%, between approximately 0% and 2%, between approximately 0% and 3%, between approximately 0% and 4%, between approximately 0% and 5%, between approximately 0% and 6%, between approximately 0% and 7%, between approximately 0% and 8%, between approximately 0% and 9%, between approximately 0% and 10%, between approximately 0% and 11%, between approximately 0% and 12%, between approximately 0% and 13%, between approximately 0% and 14%, between approximately 0% and 15%, between approximately 0% and 20%, or between approximately 0% and 25%. In some embodiments of the invention, weight changes would be less than 0.5%, less than 1%, less than 2%, less than 3%, less than 4%, less than 5%, less than 6%, less than 7%, less than 8%, less than 9%, less than 10%, less than 1%, less than 12%, less than 13%, less than 14%, less than 15%, or less than 20% when compared to the apparatus that is not placed into a test bath and/or into the ear canal of a user.


In some embodiments of the invention, an apparatus comprising the layer of elastomer that is placed into a test bath and/or into the ear canal of a user can have changes to the tensile modulus (also referred to herein as Young's modulus) of the elastomer. In some embodiments of the invention, the change in tensile modulus would be approximately 0%. In some embodiments of the invention, changes to the tensile modulus would be between approximately 0% and 0.5%, between approximately 0% and 1%, between approximately 0% and 2%, between approximately 0% and 3%, between approximately 0% and 4%, between approximately 0% and 5%, between approximately 0% and 6%, between approximately 0% and 7%, between approximately 0% and 8%, between approximately 0% and 9%, between approximately 0% and 10%, between approximately 0% and 15%, between approximately 0% and 20%, between approximately 0% and 25%, between approximately 0% and 30%, between approximately 0% and 35%, between approximately 0% and 40%, between approximately 0% and 45%, or between approximately 0% and 50%. In some embodiments of the invention, the change in tensile modulus would be less than 0.5%, less than 1%, less than 2%, less than 3%, less than 4%, less than 5%, less than 6%, less than 7%, less than 8%, less than 9%, less than 10%, less than 11, less than 12%, less than 13%, less than 14%, less than 15%, less than 20%, less than 25%, less than 30%, less than 35%, less than 40%, less than 45%, or less than 50%. The Young's modulus can be determined, for example, by measuring the tangent value in the change of strain for a range in stress, or by dividing tensile stress by extensional strain in the elastic portion of a stress-strain curve.


In some embodiments of the invention, an apparatus comprising the layer of elastomer that is placed into a water bath can have a change in wall thickness. In some embodiments, the wall thickness changes would be approximately 0%. In some embodiments of the invention, wall thickness changes would be between approximately 0% and 0.5%, between approximately 0% and 1%, between approximately 0% and 2%, between approximately 0% and 3%, between approximately 0% and 4%, between approximately 0% and 5%, between approximately 0% and 6%, between approximately 0% and 7%, between approximately 0% and 8%, between approximately 0% and 9%, between approximately 0% and 10%, between approximately 0% and 15%, or between approximately 0% and 20%. In some embodiments of the invention, wall thickness changes would be less than 0.5%, less than 1%, less than 2%, less than 3%, less than 4%, less than 5%, less than 6%, less than 7%, less than 8%, less than 9%, less than 10%, less than 15%, or less than 20%.


In some embodiments of the invention, an apparatus comprising the layer of elastomer that is placed into a water bath can have a change in weight. In some embodiments of the invention, weight change is approximately 0% from the weight of a comparable apparatus that is not placed into a water bath. In some embodiments of the invention, weight change would be between approximately 0% and 0.5%, between approximately 0% and 1%, between approximately 0% and 2%, between approximately 0% and 3%, between approximately 0% and 4%, between approximately 0% and 5%, between approximately 0% and 6%, between approximately 0% and 7%, between approximately 0% and 8%, between approximately 0% and 9%, between approximately 0% and 10%, between approximately 0% and 11%, between approximately 0% and 12%, between approximately 0% and 13%, between approximately 0% and 14%, between approximately 0% and 15%, between approximately 0% and 20%, or between approximately 0% and 25%. In some embodiments of the invention, weight changes would be less than 0.5%, less than 1%, less than 2%, less than 3%, less than 4%, less than 5%, less than 6%, less than 7%, less than 8%, less than 9%, less than 10%, less than 11%, less than 12%, less than 13%, less than 14%, less than 15%, or less than 20% when compared to the apparatus that is not placed into a water bath.


In some embodiments of the invention, an apparatus comprising the layer of elastomer that is placed into a water bath can have changes to the tensile modulus (also referred to herein as Young's modulus) of the elastomer. In some embodiments of the invention, the change in tensile modulus would be approximately 0%. In some embodiments of the invention, changes to the tensile modulus would be between approximately 0% and 0.5%, between approximately 0% and 1%, between approximately 0% and 2%, between approximately 0% and 3%, between approximately 0% and 4%, between approximately 0% and 5%, between approximately 0% and 6%, between approximately 0% and 7%, between approximately 0% and 8%, between approximately 0% and 9%, between approximately 0% and 10%, between approximately 0% and 15%, between approximately 0% and 20%, between approximately 0% and 25%, between approximately 0% and 30%, between approximately 0% and 35%, between approximately 0% and 40%, between approximately 0% and 45%, or between approximately 0% and 50%. In some embodiments of the invention, the change in tensile modulus would be less than 0.5%, less than 1%, less than 2%, less than 3%, less than 4%, less than 5%, less than 6%, less than 7%, less than 8%, less than 9%, less than 10%, less than 1%, less than 12%, less than 13%, less than 14%, less than 15%, less than 20%, less than 25%, less than 30%, less than 35%, less than 40%, less than 45%, less than 50%, less than 55%, less than 60%, less than 65%, less than 70%, or less than 75% following exposure to a test bath for 16 days at 37° C., wherein the test bath comprises 10 wt % Synthetic Cerumen, 10 wt % EN1811 Sweat, and 80 wt % mineral oil. The Young's modulus can be determined, for example, by measuring the tangent value in the change of strain for a range in stress, or by dividing tensile stress by extensional strain in the elastic portion of a stress-strain curve.


In some embodiments of the invention, the elastomer has a Young's modulus of between 0.1 MPa and 5.0 MPa, between 0.2 MPa and 4.8 MPa, between 0.3 MPa and 4.6 MPa, between 0.4 MPa and 4.3 MPa, between 0.5 MPa and 4.0 MPa, between 0.6 MPa and 3.9 MPa, between 0.7 MPa and 3.8 MPa, between 0.8 MPa and 3.7 MPa, between 0.9 MPa and 3.6 MPa, or between 1.0 MPa and 3.5 MPa. In certain embodiments of the invention, the elastomer has a Young's modulus between 0.6 MPa and 3.6 MPa. In some embodiments of the invention, the elastomer has a Young's modulus of between 1 MPa and 100 MPa, between 2 MPa and 90 MPa, between 3 MPa and 80 MPa, between 4 MPa and 70 MPa, between 5 MPa and 60 MPa, between 0.5 MPa and 50 MPa, between 1 MPa and 50 MPa, between 10 MPa and 50 MPa, between 20 MPa and 50 MPa, between 30 MPa and 50 MPa, between 40 MPa and 50 MPa, between 1 MPa and 40 MPa, between 10 MPa and 40 MPa, between 20 MPa and 40 MPa, between 30 MPa and 40 MPa, between 1 MPa and 30 MPa, between 10 MPa and 30 MPa, between 20 MPa and 30 MPa, between 1 MPa and 20 MPa, between 10 MPa and 20 MPa, or between 1 MPa and 10 MPa. In certain embodiments of the invention, the elastomer has a Young's modulus of between 5 MPa and 50 MPa. In some embodiments of the invention, the elastomer has a Young's modulus of less than 75 MPa, less than 70 Mpa, less than 65 MPa, less than 60 MPa, less than 55 MPa, less than 50 MPa, less than 45 MPa, less than 40 MPa, less than 35 MPa, less than 30 MPa, less than 25 MPa, less than 20 MPa, less than 15 MPa, less than 10 MPa, or less than 5 MPa.


In some embodiments of the invention, a suitable elastomer would meet temperature stability requirements which would ensure that key characteristics of the material would not change significantly when placed into an environment such as the ear canal of a user. In some embodiments, the elastomer is insensitive to temperatures at or near the temperature of a human ear canal. In certain embodiments, sensitivity to temperature is measured as an assessment of degradation (e.g., by microscopic analysis) following prolonged exposure (e.g., 1 month) to a temperature parameter. In some embodiments, sensitivity to temperature is determined by a change in geometric configuration, as confirmed by optical visualization, such as by scanning microscopy. In some embodiments, a elastomer is deemed insensitive to temperature following prolonged exposure if the layer of elastomer has less than 20% change in shape, less than 19% change in shape, less than 18% change in shape, less than 17% change in shape, less than 16% change in shape, less than 15% change in shape, less than 14% change in shape, less than 13% change in shape, less than 12% change in shape, less than 11% change in shape, less than 10% change in shape, less than 9% change in shape, less than 8% change in shape, less than 7% change in shape, less than 6% change in shape, less than 5% change in shape, less than 4% change in shape, less than 3% change in shape, less than 2% change in shape, less than 1% change in shape, less than 0.9% change in shape, less than 0.8% change in shape, less than 0.7% change in shape, less than 0.6% change in shape, less than 0.6% change in shape, less than 0.5% change in shape, less than 0.4% change in shape, less than 0.3% change in shape, less than 0.2% change in shape, or less than 0.1% change in shape. In some embodiments, the change in shape is measured by comparing (for example, by digitally overlaying) the platform shape before and after prolonged exposure to the temperature parameter. In some embodiments, the elastomer is insensitive to temperatures from 0° C. to 60° C., from 5° C. to 55° C., from 10° C. to 50° C., from 15° C. to 45° C., from 20° C. to 40° C., or from 25° C. to 40° C. In some embodiments, the elastomer is insensitive to temperatures from 0° C. to 100° C., from 0° C. to 90° C., from 0° C. to 80° C., from 0° C. to 70° C., from 0° C. to 60° C., from 0° C. to 55° C., from 0° C. to 50° C., from 0° C. to 45° C., or from 0° C. to 40° C. In some embodiments, the elastomer is insensitive to temperatures from 15° C. to 45° C.


In some embodiments of the invention, the suitable layer of elastomer does not display wrinkling or buckling. Wrinkling or buckling can be determined by visual inspection.


In some embodiments, the visual inspection comprises optical assistance, such as by use of a microscope or scanning microscopy.


In some embodiments, the suitable layer of elastomer is resistant to tearing on insertion and/or removal from the ear canal. In some embodiments, the suitable layer of elastomer is resistant to tearing or shape deformation during manufacture and/or clinical handling.


In some embodiments, the suitable platform material is hydrophobic. In some embodiments, the suitable platform material is hydrophilic. In certain embodiments, the suitable platform material is hydrophobic and hydrophilic (e.g., having hydrophobic regions and hydrophilic regions). In some embodiments, the suitable layer of elastomer is hydrophobic. In some embodiments, the suitable layer of elastomer is hydrophilic. In certain embodiments, the suitable layer of elastomer is hydrophobic and hydrophilic (e.g., having hydrophobic regions and hydrophilic regions). In certain embodiments, the material allows epithelial cells to pass under the perimeter platform during the natural migration of the epithelial layer, which can avoid epithelial build-up.


In some embodiments, the suitable elastomer is lipophilic. In some embodiments, the suitable elastomer is lipophobic. In some embodiments, the suitable elastomer is lipophobic and lipophilic (e.g., having lipophilic regions and lipophobic regions). In certain embodiments, the elastomer can absorb and retain mineral oil. The measurement of mineral oil absorption can be measured by the swelling of the elastomer following exposure to said mineral oil. For example, an increase of mass of an elastomer exposed to mineral oil can indicate the elastomer is swelling with mineral oil absorption. In some embodiments, the layer of elastomer mass increases by greater than 1%, greater than 2%, greater than 3%, greater than 4%, greater than 5%, greater than 6%, greater than 7%, greater than 8%, greater than 9%, greater than 10%, greater than 15%, greater than 20%, or greater than 25% following exposure of the elastomer to mineral oil. In some embodiments, the mass of the apparatus increases by greater than 1%, greater than 2%, greater than 3%, greater than 4%, greater than 5%, greater than 6%, greater than 7%, greater than 8%, greater than 9%, greater than 10%, greater than 15%, greater than 20%, or greater than 25% following exposure of the layer of elastomer to mineral oil. In some embodiments, the apparatus can elute mineral oil.


In some embodiments of the invention, the suitable layer of elastomer comprises an elastomer with an ultimate tensile strength modulus measured at an elongation of approximately 650%. In some embodiments of the invention, a suitable elastomer would have an ultimate tensile strength modulus of between approximately 1 MegaPascal (MPa) and approximately 300 MPa at an elongation of approximately 650%. In some embodiments of the invention, a suitable elastomer would have an ultimate tensile strength modulus of between 20 MPa and 100 MPa at an elongation of approximately 650%. In some embodiments of the invention, the suitable elastomer has an ultimate tensile strength modulus of between 40 MPa and 60 MPa at an elongation of approximately 650%. In some embodiments of the invention, the suitable layer has an ultimate tensile strength modulus of from 1 MPa to 500 MPa, from 5 MPa to 400 MPa, from 10 MPa to 300 MPa, from 15 MPa to 200 MPa, from 20 MPa to 150 MPa, from 25 MPa to 100 MPa, from 30 MPa to 75 MPa, from 35 MPa to 70 MPa, or from 40 MPa to 60 MPa at an elongation of approximately 650%. In some embodiments of the invention, the suitable elastomer has an ultimate tensile strength modulus of from 1 MPa to 200 MPa, from 5 MPa to 150 MPa, from 10 MPa to 100 MPa, from 15 MPa to 90 MPa, from 20 MPa to 80 MPa, from 25 MPa to 70 MPa, or from 30 MPa to 60 MPa at an elongation of approximately 650%. In some embodiments of the invention, the suitable elastomer has an ultimate tensile strength modulus less than 200 MPa, less than 150 MPa, less than 100 MPa, less than 90 MPa, less than 80 MPa, less than 70 MPa, less than 60 MPa, less than 50 MPa, or less than 40 MPa at an elongation of approximately 650%.


In some embodiments of the invention, a suitable elastomer would have optimal elasticity, including an optimal tensile stress. In some embodiments, the elastomer has a tensile stress of between 1.0 MPa and 5.0 MPa, between 1.1 MPa and 4.9 MPa, between 1.2 MPa and 4.8 MPa, between 1.3 MPa and 4.7 MPa, between 1.4 MPa and 4.6 MPa, between 1.5 MPa and 4.5 MPa, between 1.6 MPa and 4.4 MPa, between 1.7 MPa and 4.3 MPa, between 1.8 MPa and 4.2 MPa, between 1.9 MPa and 4.1 MPa, or between 2.0 MPa and 4.0 MPa at 50% elongation. In some embodiments, the suitable elastomer has a tensile stress of between 0.1 MPa and 10 MPa, between 0.2 MPa and 9 MPa, between 0.3 MPa and 8 MPa, between 0.4 MPa and 7 MPa, or between 0.5 MPa and 6 MPa at 50% elongation. In some embodiments, the suitable elastomer has a tensile stress of between approximately 2.0 MPa and approximately 4.0 MPa at 50% elongation. In some embodiments of the invention, a suitable elastomer would have a tensile stress of between approximately 2.4 MPa and approximately 4.2 MPa at 50% elongation.


In some embodiments of the invention, a suitable elastomer has a tensile stress of between 0.1 MPa and 10 MPa, between 0.5 MPa and 9 MPa, between 0.7 MPa 8 MPa, between 1.0 MPa and 7.0 MPa, between 1.1 MPa and 6.9 MPa, between 1.2 MPa and 6.8 MPa, between 1.3 MPa and 6.7 MPa, between 1.4 MPa and 6.6 MPa, between 1.5 MPa and 6.5 MPa, between 1.6 MPa and 6.4 MPa, between 1.7 MPa and 6.3 MPa, between 1.8 MPa and 6.2 MPa, between 1.9 MPa and 6.1 MPa, between 2.0 MPa and 6.0 MPa, between 2.1 MPa and 5.9 MPa, between 2.2 MPa and 5.8 MPa, between 2.3 MPa and 5.7 MPa, between 2.4 MPa and 5.6 MPa, between 2.5 MPa and 5.5 MPa, between 2.6 MPa and 5.4 MPa, between 2.7 MPa and 5.3 MPa, between 2.8 MPa and 5.2 MPa, between 2.9 MPa and 5.1 MPa, or between 3.0 MPa and 5.0 MPa at 100% elongation. In some embodiments of the invention, a suitable elastomer has a tensile stress of between 3.0 MPa and 5.0 MPa at 100% elongation. In some embodiments of the invention, a suitable elastomer would have a tensile stress of between approximately 3.4 MPa and approximately 5.5 MPa at 100% elongation.


In some embodiments, the suitable layer of elastomer has a thickness of less than 500 microns, less than 450 microns, less than 400 microns, less than 350 microns, less than 300 microns, less than 250 microns, less than 200 microns, less than 175 microns, less than 150 microns, less than 125 microns, less than 100 microns, less than 90 microns, less than 80 microns, less than 70 microns, less than 60 microns, or less than 50 microns. In some embodiments, the suitable layer of elastomer has a thickness of between 1 micron and 500 microns, between 5 microns and 500 microns, between 10 microns and 500 microns, between 15 microns and 500 microns, between 20 microns and 500 microns, between 25 microns and 500 microns, between 50 microns and 500 microns, between 75 microns and 500 microns, between 100 microns and 500 microns, between 150 microns and 500 microns, between 200 microns and 500 microns, between 250 microns and 500 microns, or between 300 microns and 500 microns. In some embodiments of the invention, a suitable layer of elastomer would have a thickness of between approximately 25 microns and approximately 500 microns. In some embodiments of the invention, a suitable layer of elastomer would have a thickness of between approximately 75 microns and approximately 500 microns.


In some embodiments, the suitable umbo platform material has a thickness of between 1 micron and 500 microns, between 5 microns and 400 microns, between 10 microns and 300 microns, between 15 microns and 200 microns, between 20 microns and 150 microns, between 25 microns and 100 microns, between 30 microns and 90 microns, between 40 microns and 80 microns, or between 50 microns and 70 microns. In some embodiments, the umbo platform material has a thickness of less than 200 microns, less than 190 microns, less than 180 microns, less than 170 microns, less than 160 microns, less than 150 microns, less than 140 microns, less than 130 microns, less than 120 microns, less than 110 microns, less than 100 microns, less than 90 microns, less than 80 microns, less than 70 microns, less than 60 microns, or less than 50 microns. In some embodiments of the invention, the suitable umbo platform material would have a thickness of between approximately 25 microns and approximately 100 microns. In some embodiments, the umbo platform material comprises a layer of elastomer. In some embodiments, the umbo platform material is a layer of elastomer.


In some embodiments of the invention, a suitable layer of elastomer would have surface characteristics which are optimized for use in a direct drive device according to the present invention. In some embodiments of the invention, an appropriate material would have surface characteristics including surface energy and surface roughness. In some embodiments, the suitable layer of elastomer has a surface air-water contact angle of between 80 degrees and 150 degrees, 85 degrees and 145 degrees, 90 degrees and 140 degrees, 95 degrees and 135 degrees, 100 degrees and 130 degrees, 101 degrees and 129 degrees, 102 degrees and 128 degrees, 103 degrees and 127 degrees, 104 degrees and 126 degrees, 105 degrees and 125 degrees, 106 degrees and 124 degrees, 107 degrees and 123 degrees, 108 degrees and 122 degrees, 109 degrees and 121 degrees, 110 degrees and 120 degrees, 119 degrees and 121 degrees, 118 degrees and 122 degrees, 117 degrees and 123 degrees, 116 degrees and 124 degrees, 115 degrees and 125 degrees, 114 degrees and 126 degrees, 113 degrees and 127 degrees, 112 degrees and 128 degrees, 111 degrees and 129 degrees, or 110 degrees and 130 degrees. In some embodiments of the invention, a suitable layer of elastomer would have a surface air-water contact angle of between approximately 100 degrees and 130 degrees. In some embodiments of the invention, a suitable layer of elastomer would have a surface air-water contact angle of approximately 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, or 130 degrees. In certain embodiments, the suitable layer of elastomer has a surface air-water contact angle of approximately 120 degrees. In some embodiments of the invention, the suitable layer of elastomer has a surface air-to-water contact angle of between 20 degrees and 80 degrees, 25 degrees and 75 degrees, 30 degrees and 70 degrees, 35 degrees and 65 degrees, or 40 degrees and 60 degrees. In some embodiments, the layer of elastomer has a surface air-to-water contact angle of less than 80 degrees, less than 75 degrees, less than 70 degrees, less than 65 degrees, less than 60 degrees, less than 55 degrees, less than 50 degrees, less than 45 degrees, less than 40 degrees, less than 35 degrees, or less than 30 degrees.


In some embodiments of the invention, a suitable platform material would include 3D printing features. In some embodiments of the invention, a suitable platform material would include 3D printing features having a depth of approximately 25 microns. In some embodiments of the invention, a suitable platform material would include a layer of elastomer having 3D printing features having a depth of approximately 25 microns. In some embodiments, the platform material comprises a layer of elastomer. In some embodiments of the invention, the tissue facing surface of a suitable platform material would include lines space at a predetermined distance apart. In some embodiments of the invention, a suitable platform material would include lines space approximately 25 microns apart. In some embodiments of the invention, the lines may result from print lines in the ear canal mold that is used to form the sulcus platform. In some embodiments of the invention, the presence of the lines may be used as an indicator that the sulcus platform was properly and uniformly deposited on the mold to accurately take the shape of the anatomy of the patient reflected in the mold. In certain embodiments, the suitable platform material comprises a layer of elastomer. In some embodiments, the suitable platform material is a layer of elastomer.


In some embodiments of the invention, a suitable platform material comprises a hardness rating measured on the Shore A hardness scale. In certain embodiments, the platform material has a hardness rating between 75 and 90 on the Shore A hardness scale. In some embodiments, the platform material has a hardness rating between 80 and 85, between 75 and 90, between 70 and 95, or between 65 and 100 on the Shore A hardness scale. In certain embodiments, the platform material comprises a layer of elastomer having a hardness rating between 75 and 90 on the Shore A hardness scale. In some embodiments, the elastomer has a hardness rating between 80 and 85, between 75 and 90, between 70 and 95, or between 65 and 100 on the Shore A hardness scale. In certain embodiments, the elastomer has a hardness rating between 0 and 100, between 10 and 100, between 20 and 100, between 30 and 100, between 40 and 100, between 50 and 100, between 60 and 100, between 70 and 100, or between 80 and 100 on the Shore A hardness scale. In some embodiments of the invention, a suitable layer of elastomer may comprise, for example, a polycarbonate-based silicone elastomer (e.g., a ChronoSil®). In some embodiments of the invention a suitable layer of elastomer may comprise, for example, an aliphatic polycarbonate-based thermoplastic urethane (e.g., ChronoFlex® AL) having a hardness rating of between approximately 75 and approximately 90 on the Shore A hardness scale.


In some embodiments of the invention, the layer of elastomer would include polydimethylsiloxane. In some embodiments, the layer of elastomer comprises from 0.1% to 25%, from 1% to 24%, from 2% to 23%, from 3% to 22%, from 4% to 21%, from 5% to 20%, from 6% to 19%, from 7% to 18%, from 8% to 17%, from 9% to 16%, from 10% to 15%, from 9% to 11%, from 8% to 12%, from 7% to 13%, from 6% to 14%, from 5% to 15%, from 1% to 2%, from 1% to 3%, from 1% to 4%, from 1% to 5%, from 1% to 6%, from 1% to 7%, from 1% to 8%, from 1% to 9%, from 1% to 10%, from 1% to 11%, from 1% to 12%, from 1% to 13%, from 1% to 14%, from 1% to 15%, from 1% to 16%, from 1% to 17%, from 1% to 18%, from 1% to 19%, or from 1% to 20% polydimethylsiloxane by weight. In some embodiments, the layer of elastomer comprises between approximately 5% and approximately 15% polydimethylsiloxane by weight. In some embodiments, the layer of elastomer comprises approximately 10% polydimethylsiloxane by weight.


In some embodiments of the invention, elastomers which have shown durability and possess elasticity making them suitable for use in a perimeter platform include polyurethanes, such as ChronoSil® (from AdvanSource Biomaterials) and BioNate® (from DSM). In some embodiments of the invention, elastomers which have shown durability and possess elasticity making them suitable for use in a perimeter platform include fluoropolymers such as polytetrafluoroethylene-co-hexafluoropropylene-co-vinylidene fluoride (from THV and THVP, 3M). In some embodiments of the invention, suitable platform materials may also include a thermoplastic elastomer comprising polyamide and polyether (e.g., Pebax® 7433 from Arkema). In some embodiments of the invention, suitable platform materials may also include polycarbonate urethane with poly(dimethyl siloxane) soft segment. In some embodiments of the invention, suitable platform materials may include polycarbonate urethane-co-poly(dimethyl siloxane).


In some embodiments, the platform material comprises a layer of elastomer. In some embodiments, the elastomer can comprise a styrenic block copolymer (SBC), a silicone rubber, an elastomeric alloy, a thermoplastic, a thermoplastic elastomer (TPE), a thermoplastic vulcanizate (TPV) elastomer, a polyurethane elastomer, a block copolymer elastomer, a polyolefin blend elastomer, a thermoplastic co-polyester elastomer, a thermoplastic polyamide elastomer, or any combination thereof (e.g., a blend of at least two of the listed materials). In some embodiments, the elastomer can comprise a polyester, a co-polyester, a polycarbonate, a thermoplastic polyurethane, a polypropylene, a polyethylene, a polypropylene and polyethylene copolymer, an acrylic, a cyclic block copolymer, a polyetheretherketone, a polyamide, a polyethylene terephthalate, a polybutylene terephthalate, a polyetherimide, a polyethersulfone, a polytrimethylene terephthalate, or any combination thereof. In some embodiments, the layer of elastomer comprises a blend, a layered material, or a combination thereof. In some embodiments, the layer of elastomer can comprise a blend of the above-disclosed elastomers, a combination of the above-disclosed elastomers, a plurality of layers comprising the above-disclosed elastomers, or any combination thereof.


In some embodiments, the elastomer can comprise a polyurethane, a polycarbonate urethane with a silicone rubber soft segment, a polycarbonate urethane, an aromatic polyurethane, a fluoropolymer, a polyetherurethane, a nylon, a polyetherblockamide, an aliphatic polyetherurethane, a polyetherurethane, a propylene, a propylene with rubber, or any combination thereof. In some embodiments, the platform material can comprise a layer of elastomer, the elastomer comprising a polyurethane (e.g., a ChronoSil®), a fluoropolymer, THV [poly(tetrafluoroethylene-co-hexafluoropropylene-co-vinylidene fluoride)], a polycarbonate urethane with poly(dimethylsiloxane) soft segment, a polycarbonate urethane-co-poly(dimethyl siloxane), any derivative thereof, or any combination thereof. In certain embodiments, the elastomer can comprise ChronoSil® 75A, Chronosil® 55D, Chronosil® 75D, Chronosil® 45D, THV 221GZ, BioNate 80A, BioNate II 80A, THVP 2030, Pebax 7233, Pebax 7433, Elastollan 85A, Elastollan 95A, THV AZ, Santoprene, Estane 58300, any derivative thereof, or any combination thereof. In some embodiments, the elastomer can comprise a silicone rubber, a poly dimethylsiloxane (PDMS), a polycarbonate urethane, a polyether urethane variotherm, a polyether urethane urea, a polyurethane poly(dimethoylsiloxane), a nitinol, Carbo 3D EPU 60, Visijet M2ENT, a poly(p-xylylene) polymer (e.g., a Parylene™), any derivative thereof, or any combination thereof. In some embodiments, the platform material comprises a blend, a layered material, or a combination thereof. In some embodiments, the platform material can comprise a blend of the above-disclosed elastomers, a combination of the above-disclosed elastomers, a plurality of layers comprising the above-disclosed elastomers, or any combination thereof.


In some embodiments, the layer of elastomer is coated with a coating polymer. The coating polymer can, for example, provide additional stiffness to the apparatus. In some embodiments, the coating polymer can provide additional features to the structure, such as increasing comfort for the user, providing increased absorption of mineral oil, or preventing deformation of the apparatus. In some embodiments, the coating polymer comprises aromatic hydrocarbon monomers. In certain embodiments, the coating polymer comprises a poly(p-xylylene) polymer (e.g., a Parylene™) or any derivative thereof. In some embodiments, the retention structure comprises the layer of elastomer coated with a coating polymer. The coating polymer can completely surround the retention structure, or can surround a portion of the retention structure. In certain embodiments, the coating polymer can surround greater than 10% of the retention structure surface area, greater than 20% of the retention structure surface area, greater than 30% of the retention structure surface area, greater than 40% of the retention structure surface area, greater than 50% of the retention structure surface area, greater than 60% of the retention structure surface area, greater than 70% of the retention structure surface area, greater than 75% of the retention structure surface area, greater than 80% of the retention structure surface area, greater than 85% of the retention structure surface area, greater than 90% of the retention structure surface area, greater than 91% of the retention structure surface area, greater than 92% of the retention structure surface area, greater than 93% of the retention structure surface area, greater than 94% of the retention structure surface area, greater than 95% of the retention structure surface area, greater than 96% of the retention structure surface area, greater than 97% of the retention structure surface area, greater than 98% of the retention structure surface area, or greater than 99% of the retention structure surface area. In certain embodiments, the coating polymer can surround greater than 10% of the layer of elastomer surface area, greater than 20% of the layer of elastomer surface area, greater than 30% of the layer of elastomer surface area, greater than 40% of the layer of elastomer surface area, greater than 50% of the layer of elastomer surface area, greater than 60% of the layer of elastomer surface area, greater than 70% of the layer of elastomer surface area, greater than 75% of the layer of elastomer surface area, greater than 80% of the layer of elastomer surface area, greater than 85% of the layer of elastomer surface area, greater than 90% of the layer of elastomer surface area, greater than 91% of the layer of elastomer surface area, greater than 92% of the layer of elastomer surface area, greater than 93% of the layer of elastomer surface area, greater than 94% of the layer of elastomer surface area, greater than 95% of the layer of elastomer surface area, greater than 96% of the layer of elastomer surface area, greater than 97% of the layer of elastomer surface area, greater than 98% of the layer of elastomer surface area, or greater than 99% of the layer of elastomer surface area.


In some embodiments of the invention, the perimeter platform may be made out of a material which can recover its intended geometry almost completely following delivery and placement. In some embodiments of the invention elastomers represent a class of materials which may address these issues.


In some embodiments of the invention, standard manufacturing methods may be used to manufacture perimeter platforms and umbo platforms using materials described herein. In some embodiments of the invention, the perimeter platform may be manufactured using a variety of methods, including vacuum forming, dip coating, thermoforming, injection molding, or blow molding. In some embodiments of the invention, in the case of blow molding, because the specific geometry of each perimeter platform is unique to an individual subject, the mold must also have a unique geometry. In some embodiments of the invention, a suitable method for preparing such a mold is by 3D printing.


In some embodiments of the invention, the term platform material may be used to refer to the perimeter platform, the sulcus platform, the retention structure, and/or the umbo platform.


In some embodiments of the invention, the perimeter platform may have a variable wall thickness, ranging between approximately 175 microns in a first region of the perimeter platform and approximately 400 microns in a second portion of the perimeter platform. In some embodiments of the invention, the umbo platform may have variable wall thicknesses, ranging from approximately 50 microns in a first region of the umbo platform to approximately 150 microns in a second region of the umbo platform.


In some embodiments of the invention, the perimeter platform may have a weight of approximately 20 milligrams. In some embodiments of the invention, the perimeter platform may have a weight in the range of between approximately 5 milligrams to approximately 20 milligrams. In some embodiments of the invention, the umbo platform may have a weight of approximately 1 milligram. In some embodiments of the invention, the umbo platform may have a weight of between approximately 1 milligram and approximately 2 milligrams.


In some embodiments of the invention, the perimeter platform and umbo platform may be coated in oil, such as, for example, mineral oil. In some embodiments, the platform material can be coated with a coating having properties similar to mineral oil. In certain embodiments, the platform material can be bonded to a coating having properties similar to mineral oil. In some embodiments, the layer of elastomer can be coated with a coating having properties similar to mineral oil. In certain embodiments, the layer of elastomer can be bonded to a coating having properties similar to mineral oil. In some embodiments, the retention structure can be coated with a coating having properties similar to mineral oil. In certain embodiments, the retention structure can be bonded to a coating having properties similar to mineral oil. In some embodiments, the similarities between the coating and the mineral oil comprise lipophilicity and/or hydrophobicity.


Methods of Using the Apparatus


In some embodiments of the invention, an apparatus as described herein can be used to provide treatment to a user in need. A method of treating a user in need of a hearing device can comprise: (i) providing the user with the apparatus as described herein; and (ii) inserting the apparatus into an ear of the user, such that a transducer on the apparatus is in proximity to the eardrum of the user. In some embodiments, the method further comprises the step of administering mineral oil to the apparatus, to the ear of the user, or any combination thereof.


Kits Comprising the Apparatus


In some embodiments of the invention, a kit comprising an apparatus as described herein is disclosed. A kit can comprise: (i) the apparatus as described herein; and (ii) instructions for using the apparatus. In some embodiments, the kit further comprises mineral oil.


Methods of Manufacturing the Apparatus


In some embodiments of the invention, a method of manufacturing an apparatus as described herein is disclosed. In some embodiments, the method of manufacturing an apparatus as described herein comprises an injection molding process. In some embodiments, the method of manufacturing an apparatus as described herein comprises a solvent coating process. In some embodiments, the method of manufacturing an apparatus as described herein comprises a 3D printing process. In some embodiments, the method of manufacturing an apparatus as described herein can comprise an injection molding process, a solvent coating process, a 3D printing process, or any combination thereof. In some embodiments, the method of manufacturing an apparatus can comprise extruding platform material in the form of extruded tubing.


EXAMPLES

The specific dimensions of any of the apparatuses, methods, kits, and components thereof, of the present disclosure can be readily varied depending upon the intended application, as will be apparent to those of skill in the art in view of the disclosure herein. Moreover, it is understood that the examples and aspects described herein are for illustrative purposes only and that various modifications or changes in light thereof can be suggested to persons skilled in the art and are included within the spirit and purview of this application and scope of the appended claims. Numerous different combinations of aspects described herein are possible, and such combinations are considered part of the present disclosure. In addition, all features discussed in connection with any one aspect herein can be readily adapted for use in other aspects herein. The use of different terms or reference numerals for similar features in different aspects does not necessarily imply differences other than those expressly set forth. Accordingly, the present disclosure is intended to be described solely by reference to the appended claims, and not limited to the aspects disclosed herein.


Example 1
Elastomer Changes Following Mineral Oil Bath Test

This example describes a procedure for simulating ear canal exposure in an ex vivo setting. This protocol provides details for testing materials to provide accelerated, and optionally head-to-head comparisons of a variety of 3D-printed polymeric materials to fluid uptake or changes in material properties when exposed to the chemical environment of the ear canal.


ChronoSil® 75A, 10% silicone that has been thermally processed by blown molding but is in the tubular area of the mold and has a regular cylindrical geometry serves as a control. Samples for testing of swelling and dimensional changes (also referred to herein as coupons) have initial dimensions of 12.5×37.5 mm with a thickness of 500 microns. Coupons are measured for length and width using calipers, and thickness using a snap gauge. Coupons are weighed using an analytical balance.


The test bath is prepared using 25 grams (10 wt %) of Synthetic Cerumen, 25 grams (10 wt %) of EN1811 Sweat, and 200 grams (80 wt %) mineral oil. The Synthetic Cerumen is prepared by mixing 240 grams (44.4 wt %) Lanolin, 120 grams (22.2 wt %) palmitic Acid, 60 grams (11.1 wt %) myristic acid, 60 grams (11.1 wt %) oleic acid, 60 grams (11.1 wt %) linoleic acid, and 0.1 grams Vitamin E. The EN1811 Sweat is prepared by mixing an aqueous solution containing 5.00 g/L (0.50 wt %) NaCl, 1.00 g/L (0.10 wt %) urea, 1.00 g/L (0.10 wt %) DL-lactic acid, and trace amounts of NH4OH sufficient to adjust the pH to approximately 6.6.


A glass beaker with the simulated canal exposure solution is placed on a hot plate with a stirrer and a thermometer. The solution temperature is maintained at either 37±2° C. for standard test conditions, or 60±2° C. for accelerated test conditions.


Material samples are conditioned in deionized water, and preliminary dimensional and weight measurements are taken. Samples are submerged into the solution, and stirring is contained at 300±50 rpm in order to maintain a singular emulsion phase. Length, width, thickness, and weight changes are measured at 1 day, 2 days, 5 days, and 16 days in standard conditions (at 5 hours, 10 hours, 1 day, and 3 days in accelerated conditions). Samples are blotted dry with a lint-free cloth prior to measuring.


In some instances, the testing samples are prepared in dog bone shape, with specific dimensions depending on the modulus of the material, such that the target test load is less than 100 N. Dog bone shaped samples are used for tensile testing. Dog bones are measured for tensile modulus after the final time point of the study (i.e., 16 days for standard conditions, and 3 days for accelerated conditions).


Samples of materials are tested for hardness using a durometer gage, both in dry state and after fluid exposure. Materials showing favorable outcomes are further studied as printed 3D perimeter platforms, which are dusted (if needed) and scanned before and after immersion in water and test bath.


Tested materials are compared to reference materials that are not exposed to the bath test, and percent changes of weight, thickness, and Young's modulus are determined. Desirable materials do not undergo substantial changes in dimensions, weight, or mechanical properties after exposure to substances commonly encountered in the ear canal, including water, sweat, mineral oil, and cerumen.


Example 2
Characterization of Elastomer Tensile Strength

This example describes a procedure for testing materials for use in apparatus described herein. This procedure is used to characterize favorable qualities relating to the tensile strength of materials.


Dog bone samples, as described in Example 1, are printed and UV-cured. A 500-N load cell on an IMADA tensile test stand is used. Cross-head speed is set to 25 mm/min. Prior to testing, samples are measured for width and thickness. Each sample is loaded into the upper grip, and attached to the lower grip. Activation of the instrument provides a force, and the load force is recorded (N), along with travel distance (inches) and stress (MPa).


Five ChronoSil® 75A samples that were thermoformed and were tested to determine tensile strength, following exposure to test bath conditions (16 day standard conditions, as described in Example 1). Initial measurements are provided in Table 1.













TABLE 1





Sample No.
Weight (g)
Length (mm)
Width (mm)
Thickness (mm)







Sample 1
0.0339
15.86
8.29
0.22


Sample 2
0.0404
15.79
8.63
0.25


Sample 3
0.0291
15.21
7.62
0.23


Sample 4
0.0435
16.81
9.41
0.23


Sample 5
0.0315
16.31
8.67
0.22










As shown in FIG. 7, force was recorded as samples were stretched to induce strain. FIG. 7 depicts stress-strain curves for the ChronoSil® 75A samples. Peak force was recorded and noted. Tensile strength was calculated by dividing the peak force of each sample by the sample's thickness and width. The calculated tensile strengths are provided in Table 2.













TABLE 2







Sample No.
Peak Force (N)
Tensile Strength (MPa)









Sample 1
7.44
4.07939



Sample 2
5.90
2.73465



Sample 3
3.80
2.16821



Sample 4
4.60
1.88016



Sample 5
5.52
2.89399










Through this protocol, tensile strength of sample materials can be determined. This procedure can similarly be used to determine information relating to materials' elastic region characteristics (e.g., Young's modulus and yield strength) and plastic region characteristics (e.g., strain hardening, necking, and fracture).


While the preferred embodiments of the devices and methods have been described in reference to the environment in which they were developed, they are merely illustrative of the principles of the present inventive concepts. Modification or combinations of the above-described assemblies, other embodiments, configurations, and methods for carrying out the invention, and variations of aspects of the invention that are obvious to those of skill in the art are intended to be within the scope of the claims. In addition, where this application has listed the steps of a method or procedure in a specific order, it may be possible, or even expedient in certain circumstances, to change the order in which some steps are performed, and it is intended that the particular steps of the method or procedure claim set forth herebelow not be construed as being order-specific unless such order specificity is expressly stated in the claim.


REFERENCE NUMBERS















Number
Element









100
Contact Hearing Device (Tympanic Lens)



130
Photodetector



140
Transducer



150
Sulcus Platform



155
Perimeter Platform



170
Chassis



180
Bias Springs



190
Grasping Tab



200
Drive Post



210
Adhesive



220
Umbo Lens



225
Oil Layer



240
Membrane



350
Transducer Reed



360
Ridges (3 D Printing



BN
Boney Portion



TA
Tympanic Annulus



TM
Tympanic Membrane



EC
Ear Canal



UM
Umbo









Claims
  • 1. An apparatus for placement with a user, the apparatus comprising: a transducer; anda retention structure comprising:a shape profile corresponding to a tissue of the user to couple the transducer to the user, wherein the retention structure maintains a location of the transducer when coupled to the user; anda layer of elastomer, wherein the elastomer has a hardness of between 0 A and 100 A, and a thickness of between approximately 25 microns and approximately 500 micronswherein the retention structure comprises a curved portion having an inner surface toward an eardrum of the patient when placed, and wherein the curved portion couples to an ear canal wall of the patient, oriented toward the eardrum when placed to couple the transducer to the eardrum, andwherein the curved portion and the second portion are connected so as to define an aperture extending therebetween to view at least a portion of the eardrum when the curved portion couples to the first side of the ear canal and the second portion couples to the second side.
  • 2. The apparatus of claim 1, wherein the elastomer has a Young's modulus of between 0.5 MPa and 50 MPa.
  • 3. The apparatus of claim 1, wherein the elastomer has a hardness of between approximately 25 A and approximately 95 A.
  • 4. The apparatus of claim 1, wherein the elastomer has an ultimate tensile strength of between 0.5 MPa and 5.0 MPa, or the elastomer has an ultimate tensile strength of between 5 MPa and 50 MPa.
  • 5. The apparatus of claim 1, wherein the elastomer has an ultimate tensile strength of between approximately 1 MPa and approximately 300 MPa, between approximately 20 MPa and approximately 100 MPa, or between approximately 40 MPa and approximately 60 MPa at an elongation of approximately 650%.
  • 6. The apparatus of claim 1, wherein the elastomer has a tensile stress of between approximately 2.0 MPa and approximately 4.0 MPa at 50% elongation.
  • 7. The apparatus of claim 1, wherein the elastomer has a tensile stress of between approximately 3.0 MPa and approximately 5.0 MPa at 100% elongation.
  • 8. The apparatus of claim 1, wherein the layer of elastomer has a change in Young's Modulus of less than 15%, less than 50%, or less than 75%, compared to a reference layer of elastomer following exposure to a test bath for 16 days at 37° C., the test bath comprising 10 wt % Synthetic Cerumen, 10 wt % EN1811 Sweat, and 80 wt % mineral oil.
  • 9. The apparatus of claim 1, wherein the layer of elastomer has a change in weight of less than 30% compared to a reference layer of elastomer, following exposure to a test bath for 16 days at 37° C., the test bath comprising 10 wt % Synthetic Cerumen, 10 wt % EN1811 Sweat, and 80 wt % mineral oil.
  • 10. The apparatus of claim 1, wherein the layer of elastomer has a change in wall thickness of less than 15% compared to a reference layer of elastomer, following exposure to a test bath for 16 days at 37° C., the test bath comprising 10 wt % Synthetic Cerumen, 10 wt % EN1811 Sweat, and 80 wt % mineral oil.
  • 11. The apparatus of claim 1, wherein the layer of elastomer further comprises between approximately 5% and approximately 15% polydimethylsiloxane by weight, or wherein the layer of elastomer comprises between approximately 9% and approximately 11% polydimethylsiloxane by weight.
  • 12. The apparatus of claim 1, wherein the layer of elastomer comprises a polyurethane, a polycarbonate urethane with a silicone rubber soft segment, a polycarbonate urethane, an aromatic polyurethane, a fluoropolymer, a polyetherurethane, a nylon, a polyetherblockamide, an aliphatic polyetherurethane, a propylene, a propylene with rubber, or any combination thereof.
  • 13. The apparatus of claim 1, wherein the layer of elastomer comprises a polycarbonate-based silicone elastomer, a polycarbonate urethane with poly(dimethylsiloxane) soft segment, a fluoropolymer, THV [poly(tetrafluoroethylene-co-hexafluoropropylene-co-vinylidene fluoride)], a polycarbonate urethane-co-poly(dimethyl siloxane), any derivative thereof, or any combination thereof.
  • 14. The apparatus of claim 1, wherein the layer of elastomer comprises one or more of aliphatic polycarbonate-based thermoplastic urethane, polycarbonate urethane with poly(dimethyl siloxane) soft segment, and polycarbonate urethane-co-poly(dimethyl siloxane).
  • 15. The apparatus of claim 1, wherein the curved portion couples to the ear canal on a first side of the ear canal opposite the eardrum, and wherein a second portion of the retention structure couples to a second side of the ear canal opposite the first side to hold the retention structure in the ear canal.
  • 16. The apparatus of claim 1, wherein the retention structure includes ridges along a tissue facing surface.
  • 17. The apparatus of claim 16, wherein the ridges are formed as part of a three dimensional printing process.
  • 18. The apparatus of claim 17, wherein the three dimensionally printed component is a mold used to form the layer of elastomer.
  • 19. The apparatus of claim 1, wherein the layer of elastomer has a surface air-water contact angle of between approximately 100 degrees and approximately 130 degrees, or wherein the layer of elastomer has a surface air-water contact angle of between approximately 115 degrees and approximately 125 degrees, or wherein the layer of elastomer has a surface air- water contact angle of between approximately 20 degrees and approximately 80 degrees.
  • 20. The apparatus of claim 1, wherein the apparatus further comprises an umbo lens, wherein the umbo lens comprises one or more of polycarbonate urethane with poly(dimethyl siloxane) soft segment or polycarbonate urethane-co-poly(dimethyl siloxane).
  • 21. The apparatus of claim 1, wherein the apparatus further comprises a coating polymer, the coating polymer comprising a poly(p-xylylene) polymer.
  • 22. The apparatus of claim 1, wherein the elastomer has a hardness of between 65 A and 100 A.
  • 23. A method of treating a user in need of a hearing device, the method comprising: providing the user with the apparatus of claim 1; andinserting the apparatus into an ear of the user, such that the transducer is in proximity to the eardrum of the user.
  • 24. The method of claim 23, further comprising the step of administering mineral oil to the apparatus, to the ear of the user, or any combination thereof.
  • 25. A kit, the kit comprising: the apparatus of claim 1; andinstructions for use of the apparatus.
  • 26. The kit of claim 25, further comprising mineral oil.
  • 27. A method of manufacturing the apparatus of claim 1, the method comprising an injection molding process.
  • 28. A method of manufacturing the apparatus of claim 1, the method comprising a solvent coating process.
  • 29. A method of manufacturing the apparatus of claim 1, the method comprising a 3D printing process.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of PCT Application No. PCT/US2019/020942, filed Mar. 6, 2019; which claims priority to U.S. Provisional Application No. 62/639,796, filed Mar. 7, 2018; the contents of which are incorporated herein by reference in their entirety.

US Referenced Citations (691)
Number Name Date Kind
2763334 Starkey Sep 1956 A
3209082 McCarrell et al. Sep 1965 A
3229049 Goldberg Jan 1966 A
3440314 Eldon Apr 1969 A
3449768 Doyle et al. Jun 1969 A
3526949 Genovese Sep 1970 A
3549818 Turner Dec 1970 A
3585416 Mellen Jun 1971 A
3594514 Wingrove Jul 1971 A
3710399 Hurst Jan 1973 A
3712962 Epley Jan 1973 A
3764748 Branch et al. Oct 1973 A
3808179 Gaylord Apr 1974 A
3870832 Fredrickson Mar 1975 A
3882285 Nunley et al. May 1975 A
3965430 Brandt Jun 1976 A
3985977 Beaty et al. Oct 1976 A
4002897 Kleinman et al. Jan 1977 A
4031318 Pitre Jun 1977 A
4061972 Burgess Dec 1977 A
4075042 Das Feb 1978 A
4098277 Mendell Jul 1978 A
4109116 Victoreen Aug 1978 A
4120570 Gaylord Oct 1978 A
4207441 Ricard et al. Jun 1980 A
4248899 Lyon et al. Feb 1981 A
4252440 Fedors et al. Feb 1981 A
4281419 Treace Aug 1981 A
4303772 Novicky Dec 1981 A
4319359 Wolf Mar 1982 A
4334315 Ono et al. Jun 1982 A
4334321 Edelman Jun 1982 A
4338929 Lundin et al. Jul 1982 A
4339954 Anson et al. Jul 1982 A
4357497 Hochmair et al. Nov 1982 A
4375016 Harada Feb 1983 A
4380689 Giannetti Apr 1983 A
4428377 Zollner et al. Jan 1984 A
4524294 Brody Jun 1985 A
4540761 Kawamura et al. Sep 1985 A
4556122 Goode Dec 1985 A
4592087 Killion May 1986 A
4606329 Hough Aug 1986 A
4611598 Hortmann et al. Sep 1986 A
4628907 Epley Dec 1986 A
4641377 Rush et al. Feb 1987 A
4652414 Schlaegel Mar 1987 A
4654554 Kishi Mar 1987 A
4689819 Killion Aug 1987 A
4696287 Hortmann et al. Sep 1987 A
4729366 Schaefer Mar 1988 A
4741339 Harrison et al. May 1988 A
4742499 Butler May 1988 A
4756312 Epley Jul 1988 A
4759070 Voroba et al. Jul 1988 A
4766607 Feldman Aug 1988 A
4774933 Hough et al. Oct 1988 A
4776322 Hough et al. Oct 1988 A
4782818 Mori Nov 1988 A
4800884 Heide et al. Jan 1989 A
4800982 Carlson Jan 1989 A
4817607 Tatge Apr 1989 A
4840178 Heide et al. Jun 1989 A
4845755 Busch et al. Jul 1989 A
4865035 Mori Sep 1989 A
4870688 Voroba et al. Sep 1989 A
4918745 Hutchison Apr 1990 A
4932405 Peeters et al. Jun 1990 A
4936305 Ashtiani et al. Jun 1990 A
4944301 Widin et al. Jul 1990 A
4948855 Novicky Aug 1990 A
4957478 Maniglia et al. Sep 1990 A
4963963 Dorman Oct 1990 A
4982434 Lenhardt et al. Jan 1991 A
4999819 Newnham et al. Mar 1991 A
5003608 Carlson Mar 1991 A
5012520 Steeger Apr 1991 A
5015224 Maniglia May 1991 A
5015225 Hough et al. May 1991 A
5031219 Ward et al. Jul 1991 A
5061282 Jacobs Oct 1991 A
5066091 Stoy et al. Nov 1991 A
5068902 Ward Nov 1991 A
5094108 Kim et al. Mar 1992 A
5117461 Moseley May 1992 A
5142186 Cross et al. Aug 1992 A
5163957 Sade et al. Nov 1992 A
5167235 Seacord et al. Dec 1992 A
5201007 Ward et al. Apr 1993 A
5220612 Tibbetts et al. Jun 1993 A
5259032 Perkins et al. Nov 1993 A
5272757 Scofield et al. Dec 1993 A
5276910 Buchele Jan 1994 A
5277694 Leysieffer et al. Jan 1994 A
5282858 Bisch et al. Feb 1994 A
5296797 Bartlett Mar 1994 A
5298692 Ikeda et al. Mar 1994 A
5338287 Miller et al. Aug 1994 A
5360388 Spindel et al. Nov 1994 A
5378933 Pfannenmueller et al. Jan 1995 A
5402496 Soli et al. Mar 1995 A
5411467 Hortmann et al. May 1995 A
5424698 Dydyk et al. Jun 1995 A
5425104 Shennib et al. Jun 1995 A
5440082 Claes Aug 1995 A
5440237 Brown et al. Aug 1995 A
5455994 Termeer et al. Oct 1995 A
5456654 Ball Oct 1995 A
5531787 Lesinski et al. Jul 1996 A
5531954 Heide et al. Jul 1996 A
5535282 Luca Jul 1996 A
5554096 Ball Sep 1996 A
5558618 Maniglia Sep 1996 A
5571148 Loeb et al. Nov 1996 A
5572594 Devoe et al. Nov 1996 A
5606621 Reiter et al. Feb 1997 A
5624376 Ball et al. Apr 1997 A
5654530 Sauer et al. Aug 1997 A
5692059 Kruger Nov 1997 A
5699809 Combs et al. Dec 1997 A
5701348 Shennib et al. Dec 1997 A
5707338 Adams et al. Jan 1998 A
5715321 Andrea et al. Feb 1998 A
5721783 Anderson Feb 1998 A
5722411 Suzuki et al. Mar 1998 A
5729077 Newnham et al. Mar 1998 A
5740258 Goodwin-Johansson Apr 1998 A
5742692 Garcia et al. Apr 1998 A
5749912 Zhang et al. May 1998 A
5762583 Adams et al. Jun 1998 A
5772575 Lesinski et al. Jun 1998 A
5774259 Saitoh et al. Jun 1998 A
5782744 Money Jul 1998 A
5788711 Lehner et al. Aug 1998 A
5795287 Ball et al. Aug 1998 A
5797834 Goode Aug 1998 A
5800336 Ball et al. Sep 1998 A
5804109 Perkins Sep 1998 A
5804907 Park et al. Sep 1998 A
5814095 Mueller et al. Sep 1998 A
5824022 Zilberman et al. Oct 1998 A
5825122 Givargizov et al. Oct 1998 A
5836863 Bushek et al. Nov 1998 A
5842967 Kroll Dec 1998 A
5851199 Peerless et al. Dec 1998 A
5857958 Ball et al. Jan 1999 A
5859916 Ball et al. Jan 1999 A
5868682 Combs et al. Feb 1999 A
5879283 Adams et al. Mar 1999 A
5888187 Jaeger et al. Mar 1999 A
5897486 Ball et al. Apr 1999 A
5899847 Adams et al. May 1999 A
5900274 Chatterjee et al. May 1999 A
5906635 Maniglia May 1999 A
5913815 Ball et al. Jun 1999 A
5922017 Bredberg et al. Jul 1999 A
5922077 Espy et al. Jul 1999 A
5935170 Haakansson et al. Aug 1999 A
5940519 Kuo Aug 1999 A
5949895 Ball et al. Sep 1999 A
5951601 Lesinski et al. Sep 1999 A
5984859 Lesinski Nov 1999 A
5987146 Pluvinage et al. Nov 1999 A
6001129 Bushek et al. Dec 1999 A
6005955 Kroll et al. Dec 1999 A
6011984 Van Antwerp et al. Jan 2000 A
6024717 Ball et al. Feb 2000 A
6038480 Hrdlicka et al. Mar 2000 A
6045528 Arenberg et al. Apr 2000 A
6050933 Bushek et al. Apr 2000 A
6067474 Schulman et al. May 2000 A
6068589 Neukermans May 2000 A
6068590 Brisken May 2000 A
6072884 Kates Jun 2000 A
6084975 Perkins Jul 2000 A
6093144 Jaeger et al. Jul 2000 A
6135612 Clore Oct 2000 A
6137889 Shennib et al. Oct 2000 A
6139488 Ball Oct 2000 A
6153966 Neukermans Nov 2000 A
6168948 Anderson et al. Jan 2001 B1
6174278 Jaeger et al. Jan 2001 B1
6175637 Fujihira et al. Jan 2001 B1
6181801 Puthuff et al. Jan 2001 B1
6190305 Ball et al. Feb 2001 B1
6190306 Kennedy Feb 2001 B1
6208445 Reime Mar 2001 B1
6216040 Harrison Apr 2001 B1
6217508 Ball et al. Apr 2001 B1
6219427 Kates et al. Apr 2001 B1
6222302 Imada et al. Apr 2001 B1
6222927 Feng et al. Apr 2001 B1
6240192 Brennan et al. May 2001 B1
6241767 Stennert et al. Jun 2001 B1
6259951 Kuzma et al. Jul 2001 B1
6261224 Adams et al. Jul 2001 B1
6264603 Kennedy Jul 2001 B1
6277148 Dormer Aug 2001 B1
6312959 Datskos Nov 2001 B1
6339648 McIntosh et al. Jan 2002 B1
6342035 Kroll et al. Jan 2002 B1
6354990 Juneau et al. Mar 2002 B1
6359993 Brimhall Mar 2002 B2
6366863 Bye et al. Apr 2002 B1
6374143 Berrang et al. Apr 2002 B1
6385363 Rajic et al. May 2002 B1
6387039 Moses May 2002 B1
6390971 Adams et al. May 2002 B1
6393130 Stonikas et al. May 2002 B1
6422991 Jaeger Jul 2002 B1
6432248 Popp et al. Aug 2002 B1
6434246 Kates et al. Aug 2002 B1
6434247 Kates et al. Aug 2002 B1
6436028 Dormer Aug 2002 B1
6438244 Juneau et al. Aug 2002 B1
6445799 Taenzer et al. Sep 2002 B1
6473512 Juneau et al. Oct 2002 B1
6475134 Ball et al. Nov 2002 B1
6491622 Kasic, II et al. Dec 2002 B1
6491644 Vujanic et al. Dec 2002 B1
6491722 Kroll et al. Dec 2002 B1
6493453 Glendon Dec 2002 B1
6493454 Loi et al. Dec 2002 B1
6498858 Kates Dec 2002 B2
6507758 Greenberg et al. Jan 2003 B1
6519376 Biagi et al. Feb 2003 B2
6523985 Hamanaka et al. Feb 2003 B2
6536530 Schultz et al. Mar 2003 B2
6537200 Leysieffer et al. Mar 2003 B2
6547715 Mueller et al. Apr 2003 B1
6549633 Westermann Apr 2003 B1
6549635 Gebert Apr 2003 B1
6554761 Puria et al. Apr 2003 B1
6575894 Leysieffer et al. Jun 2003 B2
6592513 Kroll et al. Jul 2003 B1
6603860 Taenzer et al. Aug 2003 B1
6620110 Schmid Sep 2003 B2
6626822 Jaeger et al. Sep 2003 B1
6629922 Puria et al. Oct 2003 B1
6631196 Taenzer et al. Oct 2003 B1
6643378 Schumaier Nov 2003 B2
6663575 Leysieffer Dec 2003 B2
6668062 Luo et al. Dec 2003 B1
6676592 Ball et al. Jan 2004 B2
6681022 Puthuff et al. Jan 2004 B1
6695943 Juneau et al. Feb 2004 B2
6697674 Leysieffer Feb 2004 B2
6724902 Shennib et al. Apr 2004 B1
6726618 Miller Apr 2004 B2
6726718 Carlyle et al. Apr 2004 B1
6727789 Tibbetts et al. Apr 2004 B2
6728024 Ribak Apr 2004 B2
6735318 Cho May 2004 B2
6754358 Boesen et al. Jun 2004 B1
6754359 Svean et al. Jun 2004 B1
6754537 Harrison et al. Jun 2004 B1
6785394 Olsen et al. Aug 2004 B1
6792114 Kates et al. Sep 2004 B1
6801629 Brimhall et al. Oct 2004 B2
6829363 Sacha Dec 2004 B2
6831986 Kates Dec 2004 B2
6837857 Stirnemann Jan 2005 B2
6842647 Griffith et al. Jan 2005 B1
6888949 Vanden Berghe et al. May 2005 B1
6900926 Ribak May 2005 B2
6912289 Vonlanthen et al. Jun 2005 B2
6920340 Laderman Jul 2005 B2
6931231 Griffin Aug 2005 B1
6940988 Shennib et al. Sep 2005 B1
6940989 Shennib et al. Sep 2005 B1
6942989 Felkner Sep 2005 B2
D512979 Corcoran et al. Dec 2005 S
6975402 Bisson et al. Dec 2005 B2
6978159 Feng et al. Dec 2005 B2
7020297 Fang et al. Mar 2006 B2
7024010 Saunders et al. Apr 2006 B2
7043037 Lichtblau et al. May 2006 B2
7050675 Zhou et al. May 2006 B2
7050876 Fu et al. May 2006 B1
7057256 Mazur et al. Jun 2006 B2
7058182 Kates Jun 2006 B2
7058188 Allred Jun 2006 B1
7072475 Denap et al. Jul 2006 B1
7076076 Bauman Jul 2006 B2
7095981 Voroba et al. Aug 2006 B1
7167572 Harrison et al. Jan 2007 B1
7174026 Niederdrank et al. Feb 2007 B2
7179238 Hissong Feb 2007 B2
7181034 Armstrong Feb 2007 B2
7203331 Boesen Apr 2007 B2
7239069 Cho Jul 2007 B2
7245732 Jorgensen et al. Jul 2007 B2
7255457 Ducharme et al. Aug 2007 B2
7266208 Charvin et al. Sep 2007 B2
7289639 Abel et al. Oct 2007 B2
7313245 Shennib Dec 2007 B1
7315211 Lee et al. Jan 2008 B1
7322930 Jaeger et al. Jan 2008 B2
7349741 Maltan et al. Mar 2008 B2
7354792 Mazur et al. Apr 2008 B2
7376563 Leysieffer et al. May 2008 B2
7390689 Mazur et al. Jun 2008 B2
7394909 Widmer et al. Jul 2008 B1
7421087 Perkins et al. Sep 2008 B2
7424122 Ryan Sep 2008 B2
7444877 Li et al. Nov 2008 B2
7547275 Cho et al. Jun 2009 B2
7630646 Anderson et al. Dec 2009 B2
7645877 Gmeiner et al. Jan 2010 B2
7668325 Puria et al. Feb 2010 B2
7747295 Choi Jun 2010 B2
7778434 Juneau et al. Aug 2010 B2
7809150 Natarajan et al. Oct 2010 B2
7822215 Carazo et al. Oct 2010 B2
7826632 Von Buol et al. Nov 2010 B2
7853033 Maltan et al. Dec 2010 B2
7867160 Pluvinage et al. Jan 2011 B2
7883535 Cantin et al. Feb 2011 B2
7885359 Meltzer Feb 2011 B2
7955249 Perkins et al. Jun 2011 B2
7983435 Moses Jul 2011 B2
8090134 Takigawa et al. Jan 2012 B2
8099169 Karunasiri Jan 2012 B1
8116494 Rass Feb 2012 B2
8128551 Jolly Mar 2012 B2
8157730 LeBoeuf et al. Apr 2012 B2
8197461 Arenberg et al. Jun 2012 B1
8204786 LeBoeuf et al. Jun 2012 B2
8233651 Haller Jul 2012 B1
8251903 LeBoeuf et al. Aug 2012 B2
8284970 Sacha Oct 2012 B2
8295505 Weinans et al. Oct 2012 B2
8295523 Fay et al. Oct 2012 B2
8320601 Takigawa et al. Nov 2012 B2
8320982 LeBoeuf et al. Nov 2012 B2
8340310 Ambrose et al. Dec 2012 B2
8340335 Shennib Dec 2012 B1
8391527 Feucht et al. Mar 2013 B2
8396235 Gebhardt et al. Mar 2013 B2
8396239 Fay et al. Mar 2013 B2
8401212 Puria et al. Mar 2013 B2
8401214 Perkins et al. Mar 2013 B2
8506473 Puria Aug 2013 B2
8512242 LeBoeuf et al. Aug 2013 B2
8526651 Lafort et al. Sep 2013 B2
8526652 Ambrose et al. Sep 2013 B2
8526971 Giniger et al. Sep 2013 B2
8545383 Wenzel et al. Oct 2013 B2
8600089 Wenzel et al. Dec 2013 B2
8647270 LeBoeuf et al. Feb 2014 B2
8652040 LeBoeuf et al. Feb 2014 B2
8684922 Tran Apr 2014 B2
8696054 Crum Apr 2014 B2
8696541 Pluvinage et al. Apr 2014 B2
8700111 LeBoeuf et al. Apr 2014 B2
8702607 LeBoeuf et al. Apr 2014 B2
8715152 Puria et al. May 2014 B2
8715153 Puria et al. May 2014 B2
8715154 Perkins et al. May 2014 B2
8761423 Wagner et al. Jun 2014 B2
8787609 Perkins et al. Jul 2014 B2
8788002 LeBoeuf et al. Jul 2014 B2
8817998 Inoue Aug 2014 B2
8824715 Fay et al. Sep 2014 B2
8837758 Knudsen Sep 2014 B2
8845705 Perkins et al. Sep 2014 B2
8855323 Kroman Oct 2014 B2
8858419 Puria et al. Oct 2014 B2
8885860 Djalilian et al. Nov 2014 B2
8886269 LeBoeuf et al. Nov 2014 B2
8888701 LeBoeuf et al. Nov 2014 B2
8923941 LeBoeuf et al. Dec 2014 B2
8929965 LeBoeuf et al. Jan 2015 B2
8929966 LeBoeuf et al. Jan 2015 B2
8934952 LeBoeuf et al. Jan 2015 B2
8942776 LeBoeuf et al. Jan 2015 B2
8961415 LeBoeuf et al. Feb 2015 B2
8986187 Perkins et al. Mar 2015 B2
8989830 LeBoeuf et al. Mar 2015 B2
9044180 LeBoeuf et al. Jun 2015 B2
9049528 Fay et al. Jun 2015 B2
9055379 Puria et al. Jun 2015 B2
9131312 LeBoeuf et al. Sep 2015 B2
9154891 Puria et al. Oct 2015 B2
9211069 Larsen et al. Dec 2015 B2
9226083 Puria et al. Dec 2015 B2
9277335 Perkins et al. Mar 2016 B2
9289135 LeBoeuf et al. Mar 2016 B2
9289175 LeBoeuf et al. Mar 2016 B2
9301696 LeBoeuf et al. Apr 2016 B2
9314167 LeBoeuf et al. Apr 2016 B2
9392377 Olsen et al. Jul 2016 B2
9427191 LeBoeuf Aug 2016 B2
9497556 Kaltenbacher et al. Nov 2016 B2
9521962 LeBoeuf Dec 2016 B2
9524092 Ren et al. Dec 2016 B2
9538921 LeBoeuf et al. Jan 2017 B2
9544700 Puria et al. Jan 2017 B2
9564862 Hoyerby Feb 2017 B2
9591409 Puria et al. Mar 2017 B2
9749758 Puria et al. Aug 2017 B2
9750462 LeBoeuf et al. Sep 2017 B2
9788785 LeBoeuf Oct 2017 B2
9788794 LeBoeuf et al. Oct 2017 B2
9794653 Aumer et al. Oct 2017 B2
9794688 You Oct 2017 B2
9801552 Romesburg Oct 2017 B2
9808204 LeBoeuf et al. Nov 2017 B2
9924276 Wenzel Mar 2018 B2
9930458 Freed et al. Mar 2018 B2
9949035 Rucker et al. Apr 2018 B2
9949039 Perkins et al. Apr 2018 B2
9949045 Kure et al. Apr 2018 B2
9961454 Puria et al. May 2018 B2
9964672 Phair et al. May 2018 B2
10003888 Stephanou et al. Jun 2018 B2
10034103 Puria et al. Jul 2018 B2
10143592 Goldstein Dec 2018 B2
10154352 Perkins et al. Dec 2018 B2
10178483 Teran et al. Jan 2019 B2
10206045 Kaltenbacher et al. Feb 2019 B2
10237663 Puria et al. Mar 2019 B2
10284964 Olsen et al. May 2019 B2
10286215 Perkins et al. May 2019 B2
10292601 Perkins et al. May 2019 B2
10306381 Sandhu et al. May 2019 B2
10492010 Rucker et al. Nov 2019 B2
10511913 Puria et al. Dec 2019 B2
10516946 Puria et al. Dec 2019 B2
10516949 Puria et al. Dec 2019 B2
10516950 Perkins et al. Dec 2019 B2
10516951 Wenzel Dec 2019 B2
10531206 Freed et al. Jan 2020 B2
10555100 Perkins et al. Feb 2020 B2
10609492 Olsen et al. Mar 2020 B2
10743110 Puria et al. Aug 2020 B2
10779094 Rucker et al. Sep 2020 B2
10863286 Perkins et al. Dec 2020 B2
11057714 Puria et al. Jul 2021 B2
11058305 Perkins et al. Jul 2021 B2
11070927 Rucker et al. Jul 2021 B2
11102594 Shaquer et al. Aug 2021 B2
11153697 Olsen et al. Oct 2021 B2
11166114 Perkins et al. Nov 2021 B2
11212626 Larkin et al. Dec 2021 B2
11252516 Wenzel Feb 2022 B2
11259129 Freed et al. Feb 2022 B2
11310605 Puria et al. Apr 2022 B2
11317224 Puria Apr 2022 B2
11337012 Atamaniuk et al. May 2022 B2
11350226 Sandhu et al. May 2022 B2
20010003788 Ball et al. Jun 2001 A1
20010007050 Adelman Jul 2001 A1
20010024507 Boesen Sep 2001 A1
20010027342 Dormer Oct 2001 A1
20010029313 Kennedy Oct 2001 A1
20010053871 Zilberman et al. Dec 2001 A1
20020025055 Stonikas et al. Feb 2002 A1
20020035309 Leysieffer Mar 2002 A1
20020048374 Soli et al. Apr 2002 A1
20020085728 Shennib et al. Jul 2002 A1
20020086715 Sahagen Jul 2002 A1
20020172350 Edwards et al. Nov 2002 A1
20020183587 Dormer Dec 2002 A1
20030021903 Shlenker et al. Jan 2003 A1
20030055311 Neukermans et al. Mar 2003 A1
20030064746 Rader et al. Apr 2003 A1
20030081803 Petilli et al. May 2003 A1
20030097178 Roberson et al. May 2003 A1
20030125602 Sokolich et al. Jul 2003 A1
20030142841 Wiegand Jul 2003 A1
20030208099 Ball Nov 2003 A1
20030208888 Fearing et al. Nov 2003 A1
20040093040 Boylston et al. May 2004 A1
20040121291 Knapp et al. Jun 2004 A1
20040158157 Jensen et al. Aug 2004 A1
20040165742 Shennib et al. Aug 2004 A1
20040166495 Greinwald, Jr. et al. Aug 2004 A1
20040167377 Schafer et al. Aug 2004 A1
20040190734 Kates Sep 2004 A1
20040202339 O'Brien, Jr. et al. Oct 2004 A1
20040202340 Armstrong et al. Oct 2004 A1
20040208333 Cheung et al. Oct 2004 A1
20040234089 Rembrand et al. Nov 2004 A1
20040234092 Wada et al. Nov 2004 A1
20040236416 Falotico Nov 2004 A1
20040240691 Grafenberg Dec 2004 A1
20050018859 Buchholz Jan 2005 A1
20050020873 Berrang et al. Jan 2005 A1
20050036639 Bachler et al. Feb 2005 A1
20050038498 Dubrow et al. Feb 2005 A1
20050088435 Geng Apr 2005 A1
20050101830 Easter et al. May 2005 A1
20050111683 Chabries et al. May 2005 A1
20050117765 Meyer et al. Jun 2005 A1
20050190939 Fretz Sep 2005 A1
20050196005 Shennib et al. Sep 2005 A1
20050222823 Brumback et al. Oct 2005 A1
20050226446 Luo et al. Oct 2005 A1
20050267549 Della et al. Dec 2005 A1
20050271870 Jackson Dec 2005 A1
20050288739 Hassler, Jr. et al. Dec 2005 A1
20060058573 Neisz et al. Mar 2006 A1
20060062420 Araki Mar 2006 A1
20060074159 Lu et al. Apr 2006 A1
20060075175 Jensen et al. Apr 2006 A1
20060161227 Walsh et al. Jul 2006 A1
20060161255 Zarowski et al. Jul 2006 A1
20060177079 Baekgaard Jensen et al. Aug 2006 A1
20060177082 Solomito et al. Aug 2006 A1
20060183965 Kasic et al. Aug 2006 A1
20060231914 Carey et al. Oct 2006 A1
20060233398 Husung Oct 2006 A1
20060237126 Guffrey et al. Oct 2006 A1
20060247735 Honert et al. Nov 2006 A1
20060256989 Olsen et al. Nov 2006 A1
20060278245 Gan Dec 2006 A1
20070030990 Fischer Feb 2007 A1
20070036377 Stirnemann Feb 2007 A1
20070076913 Schanz Apr 2007 A1
20070083078 Easter et al. Apr 2007 A1
20070100197 Perkins et al. May 2007 A1
20070127748 Carlile et al. Jun 2007 A1
20070127752 Armstrong Jun 2007 A1
20070127766 Combest Jun 2007 A1
20070135870 Shanks et al. Jun 2007 A1
20070161848 Dalton et al. Jul 2007 A1
20070191673 Ball et al. Aug 2007 A1
20070201713 Fang et al. Aug 2007 A1
20070206825 Thomasson Sep 2007 A1
20070223755 Salvetti et al. Sep 2007 A1
20070225776 Fritsch et al. Sep 2007 A1
20070236704 Carr et al. Oct 2007 A1
20070250119 Tyler et al. Oct 2007 A1
20070251082 Milojevic et al. Nov 2007 A1
20070258507 Lee et al. Nov 2007 A1
20070286429 Grafenberg et al. Dec 2007 A1
20080021518 Hochmair et al. Jan 2008 A1
20080051623 Schneider et al. Feb 2008 A1
20080054509 Berman et al. Mar 2008 A1
20080063228 Mejia et al. Mar 2008 A1
20080063231 Juneau et al. Mar 2008 A1
20080077198 Webb et al. Mar 2008 A1
20080089292 Kitazoe et al. Apr 2008 A1
20080107292 Kornagel May 2008 A1
20080123866 Rule et al. May 2008 A1
20080130927 Theverapperuma et al. Jun 2008 A1
20080188707 Bernard et al. Aug 2008 A1
20080298600 Poe et al. Dec 2008 A1
20080300703 Widmer et al. Dec 2008 A1
20090016553 Ho et al. Jan 2009 A1
20090023976 Cho et al. Jan 2009 A1
20090043149 Abel et al. Feb 2009 A1
20090076581 Gibson Mar 2009 A1
20090131742 Cho et al. May 2009 A1
20090141919 Spitaels et al. Jun 2009 A1
20090149697 Steinhardt et al. Jun 2009 A1
20090157143 Edler et al. Jun 2009 A1
20090175474 Salvetti et al. Jul 2009 A1
20090246627 Park Oct 2009 A1
20090253951 Ball et al. Oct 2009 A1
20090262966 Vestergaard et al. Oct 2009 A1
20090281367 Cho et al. Nov 2009 A1
20090310805 Petroff Dec 2009 A1
20090316922 Merks et al. Dec 2009 A1
20100036488 De Juan, Jr. et al. Feb 2010 A1
20100085176 Flick Apr 2010 A1
20100103404 Remke et al. Apr 2010 A1
20100114190 Bendett et al. May 2010 A1
20100145135 Ball et al. Jun 2010 A1
20100171369 Baarman et al. Jul 2010 A1
20100172507 Merks Jul 2010 A1
20100177918 Keady et al. Jul 2010 A1
20100222639 Purcell et al. Sep 2010 A1
20100260364 Merks Oct 2010 A1
20100272299 Van Schuylenbergh et al. Oct 2010 A1
20100290653 Wiggins et al. Nov 2010 A1
20100322452 Ladabaum Dec 2010 A1
20110062793 Azancot et al. Mar 2011 A1
20110069852 Arndt et al. Mar 2011 A1
20110084654 Julstrom et al. Apr 2011 A1
20110112462 Parker et al. May 2011 A1
20110116666 Dittberner et al. May 2011 A1
20110125222 Perkins et al. May 2011 A1
20110130622 Ilberg et al. Jun 2011 A1
20110144414 Spearman et al. Jun 2011 A1
20110164771 Jensen et al. Jul 2011 A1
20110196460 Weiss Aug 2011 A1
20110221391 Won et al. Sep 2011 A1
20110249845 Kates Oct 2011 A1
20110249847 Salvetti et al. Oct 2011 A1
20110257290 Zeller et al. Oct 2011 A1
20110258839 Probst Oct 2011 A1
20110271965 Parkins et al. Nov 2011 A1
20120008807 Gran Jan 2012 A1
20120038881 Amirparviz et al. Feb 2012 A1
20120039493 Rucker et al. Feb 2012 A1
20120092461 Fisker et al. Apr 2012 A1
20120114157 Arndt et al. May 2012 A1
20120140967 Aubert et al. Jun 2012 A1
20120217087 Ambrose et al. Aug 2012 A1
20120236524 Pugh et al. Sep 2012 A1
20120263339 Funahashi Oct 2012 A1
20130004004 Zhao et al. Jan 2013 A1
20130034258 Lin Feb 2013 A1
20130083938 Bakalos et al. Apr 2013 A1
20130089227 Kates Apr 2013 A1
20130195300 Larsen et al. Aug 2013 A1
20130230204 Monahan et al. Sep 2013 A1
20130303835 Koskowich Nov 2013 A1
20130308782 Dittberner et al. Nov 2013 A1
20130308807 Burns Nov 2013 A1
20130343584 Bennett et al. Dec 2013 A1
20130343585 Bennett et al. Dec 2013 A1
20130343587 Naylor et al. Dec 2013 A1
20140084698 Asanuma et al. Mar 2014 A1
20140107423 Yaacobi Apr 2014 A1
20140153761 Shennib et al. Jun 2014 A1
20140169603 Sacha et al. Jun 2014 A1
20140177863 Parkins Jun 2014 A1
20140194891 Shahoian Jul 2014 A1
20140254856 Blick et al. Sep 2014 A1
20140286514 Pluvinage et al. Sep 2014 A1
20140288356 Van Vlem Sep 2014 A1
20140288358 Puria et al. Sep 2014 A1
20140296620 Puria et al. Oct 2014 A1
20140321657 Stirnemann Oct 2014 A1
20140379874 Starr et al. Dec 2014 A1
20150021568 Gong et al. Jan 2015 A1
20150049889 Bern Feb 2015 A1
20150117689 Bergs et al. Apr 2015 A1
20150124985 Kim et al. May 2015 A1
20150201269 Dahl Jul 2015 A1
20150222978 Murozaki Aug 2015 A1
20150245131 Facteau et al. Aug 2015 A1
20150358743 Killion Dec 2015 A1
20160008176 Goldstein Jan 2016 A1
20160064814 Jang et al. Mar 2016 A1
20160087687 Kesler et al. Mar 2016 A1
20160094043 Hao et al. Mar 2016 A1
20160277854 Puria et al. Sep 2016 A1
20160309265 Pluvinage et al. Oct 2016 A1
20160309266 Olsen et al. Oct 2016 A1
20160330555 Vonlanthen et al. Nov 2016 A1
20170040012 Goldstein Feb 2017 A1
20170095202 Facteau et al. Apr 2017 A1
20170180888 Andersson et al. Jun 2017 A1
20170195806 Atamaniuk et al. Jul 2017 A1
20170257710 Parker Sep 2017 A1
20180077503 Shaquer et al. Mar 2018 A1
20180077504 Shaquer et al. Mar 2018 A1
20180213331 Rucker et al. Jul 2018 A1
20180262846 Perkins et al. Sep 2018 A1
20180317026 Puria Nov 2018 A1
20180376255 Parker Dec 2018 A1
20190158961 Puria et al. May 2019 A1
20190166438 Perkins et al. May 2019 A1
20190230449 Puria Jul 2019 A1
20190239005 Sandhu et al. Aug 2019 A1
20190253811 Unno et al. Aug 2019 A1
20190253815 Atamaniuk et al. Aug 2019 A1
20190269336 Perkins et al. Sep 2019 A1
20200037082 Perkins et al. Jan 2020 A1
20200068323 Perkins et al. Feb 2020 A1
20200084551 Puria et al. Mar 2020 A1
20200084553 Perkins et al. Mar 2020 A1
20200092662 Wenzel Mar 2020 A1
20200092664 Freed et al. Mar 2020 A1
20200128338 Shaquer et al. Apr 2020 A1
20200186941 Olsen et al. Jun 2020 A1
20200186942 Flaherty et al. Jun 2020 A1
20200304927 Shaquer et al. Sep 2020 A1
20200336843 Lee et al. Oct 2020 A1
20200374639 Rucker et al. Nov 2020 A1
20210029451 Fitz et al. Jan 2021 A1
20210029474 Larkin et al. Jan 2021 A1
20210186343 Perkins et al. Jun 2021 A1
20210266686 Puria et al. Aug 2021 A1
20210274293 Perkins et al. Sep 2021 A1
20210289301 Atamaniuk et al. Sep 2021 A1
20210306777 Rucker et al. Sep 2021 A1
20210314712 Shaquer et al. Oct 2021 A1
20210392449 Flaherty et al. Dec 2021 A1
20210400405 Perkins et al. Dec 2021 A1
20220007114 Perkins et al. Jan 2022 A1
20220007115 Perkins et al. Jan 2022 A1
20220007118 Rucker et al. Jan 2022 A1
20220007120 Olsen et al. Jan 2022 A1
20220046366 Larkin et al. Feb 2022 A1
20220086572 Flaherty et al. Mar 2022 A1
20220150650 Rucker May 2022 A1
Foreign Referenced Citations (123)
Number Date Country
2004301961 Feb 2005 AU
2242545 Sep 2009 CA
1176731 Mar 1998 CN
101459868 Jun 2009 CN
101489171 Jul 2009 CN
102301747 Dec 2011 CN
105491496 Apr 2016 CN
2044870 Mar 1972 DE
3243850 May 1984 DE
3508830 Sep 1986 DE
102013114771 Jun 2015 DE
0092822 Nov 1983 EP
0242038 Oct 1987 EP
0291325 Nov 1988 EP
0296092 Dec 1988 EP
0242038 May 1989 EP
0296092 Aug 1989 EP
0352954 Jan 1990 EP
0291325 Jun 1990 EP
0352954 Aug 1991 EP
1035753 Sep 2000 EP
1435757 Jul 2004 EP
1845919 Oct 2007 EP
1955407 Aug 2008 EP
1845919 Sep 2010 EP
2272520 Jan 2011 EP
2301262 Mar 2011 EP
2752030 Jul 2014 EP
3101519 Dec 2016 EP
2425502 Jan 2017 EP
2907294 May 2017 EP
3183814 Jun 2017 EP
3094067 Oct 2017 EP
3006079 Mar 2019 EP
2455820 Nov 1980 FR
2085694 Apr 1982 GB
S60154800 Aug 1985 JP
S621726 Jan 1987 JP
S6443252 Feb 1989 JP
H09327098 Dec 1997 JP
2000504913 Apr 2000 JP
2004187953 Jul 2004 JP
2004193908 Jul 2004 JP
2005516505 Jun 2005 JP
2006060833 Mar 2006 JP
100624445 Sep 2006 KR
WO-9209181 May 1992 WO
WO-9501678 Jan 1995 WO
WO-9621334 Jul 1996 WO
WO-9736457 Oct 1997 WO
WO-9745074 Dec 1997 WO
WO-9806236 Feb 1998 WO
WO-9903146 Jan 1999 WO
WO-9915111 Apr 1999 WO
WO-0022875 Apr 2000 WO
WO-0022875 Jul 2000 WO
WO-0150815 Jul 2001 WO
WO-0158206 Aug 2001 WO
WO-0176059 Oct 2001 WO
WO-0158206 Feb 2002 WO
WO-0239874 May 2002 WO
WO-0239874 Feb 2003 WO
WO-03030772 Apr 2003 WO
WO-03063542 Jul 2003 WO
WO-03063542 Jan 2004 WO
WO-2004010733 Jan 2004 WO
WO-2005015952 Feb 2005 WO
WO-2005107320 Nov 2005 WO
WO-2006014915 Feb 2006 WO
WO-2006037156 Apr 2006 WO
WO-2006039146 Apr 2006 WO
WO-2006042298 Apr 2006 WO
WO-2006071210 Jul 2006 WO
WO-2006075169 Jul 2006 WO
WO-2006075175 Jul 2006 WO
WO-2006118819 Nov 2006 WO
WO-2006042298 Dec 2006 WO
WO-2007023164 Mar 2007 WO
WO-2009046329 Apr 2009 WO
WO-2009047370 Apr 2009 WO
WO-2009049320 Apr 2009 WO
WO-2009056167 May 2009 WO
WO-2009062142 May 2009 WO
WO-2009047370 Jul 2009 WO
WO-2009125903 Oct 2009 WO
WO-2009145842 Dec 2009 WO
WO-2009146151 Dec 2009 WO
WO-2009155358 Dec 2009 WO
WO-2009155361 Dec 2009 WO
WO-2009155385 Dec 2009 WO
WO-2010033932 Mar 2010 WO
WO-2010033933 Mar 2010 WO
WO-2010077781 Jul 2010 WO
WO-2010147935 Dec 2010 WO
WO-2010148345 Dec 2010 WO
WO-2011005500 Jan 2011 WO
WO-2012088187 Jun 2012 WO
WO-2012149970 Nov 2012 WO
WO-2013016336 Jan 2013 WO
WO-2016011044 Jan 2016 WO
WO-2016045709 Mar 2016 WO
WO-2016146487 Sep 2016 WO
WO-2017045700 Mar 2017 WO
WO-2017059218 Apr 2017 WO
WO-2017059240 Apr 2017 WO
WO-2017116791 Jul 2017 WO
WO-2017116865 Jul 2017 WO
WO-2018048794 Mar 2018 WO
WO-2018081121 May 2018 WO
WO-2018093733 May 2018 WO
WO-2019055308 Mar 2019 WO
WO-2019173470 Sep 2019 WO
WO-2019199680 Oct 2019 WO
WO-2019199683 Oct 2019 WO
WO-2020028082 Feb 2020 WO
WO-2020028083 Feb 2020 WO
WO-2020028084 Feb 2020 WO
WO-2020028085 Feb 2020 WO
WO-2020028086 Feb 2020 WO
WO-2020028087 Feb 2020 WO
WO-2020028088 Feb 2020 WO
WO-2020176086 Sep 2020 WO
WO-2021003087 Jan 2021 WO
Non-Patent Literature Citations (147)
Entry
Asbeck, et al. Scaling Hard Vertical Surfaces with Compliant Microspine Arrays, The International Journal of Robotics Research 2006; 25; 1165-79.
Atasoy [Paper] Opto-acoustic Imaging. for BYM504E Biomedical Imaging Systems class at ITU, downloaded from the Internet www2.itu.edu.td—cilesiz/courses/BYM504- 2005-OA504041413.pdf, 14 pages.
Athanassiou, et al. Laser controlled photomechanical actuation of photochromic polymers Microsystems. Rev. Adv. Mater. Sci. 2003; 5:245-251.
Autumn, et al. Dynamics of geckos running vertically, The Journal of Experimental Biology 209, 260-272, (2006).
Autumn, et al., Evidence for van der Waals adhesion in gecko setae, www.pnas.orgycgiydoiy10.1073ypnas.192252799 (2002).
Ayatollahi, et al. Design and Modeling of Micromachined Condenser MEMS Loudspeaker using Permanent Magnet Neodymium-Iron-Boron (Nd—Fe—B). IEEE International Conference on Semiconductor Electronics, 2006. ICSE '06, Oct. 29, 2006-Dec. 1, 2006; 160-166.
Baer, et al. Effects of Low Pass Filtering on the Intelligibility of Speech in Noise for People With and Without Dead Regions at High Frequencies. J. Acost. Soc. Am 112 (3), pt. 1, (Sep. 2002), pp. 1133-1144.
Best, et al. The influence of high frequencies on speech localization. Abstract 981 (Feb. 24, 2003) from www.aro.org/abstracts/abstracts.html.
Birch, et al. Microengineered systems for the hearing impaired. IEE Colloquium on Medical Applications of Microengineering, Jan. 31, 1996; pp. 2/1-2/5.
Boedts. Tympanic epithelial migration, Clinical Otolaryngology 1978, 3, 249-253.
Burkhard, et al. Anthropometric Manikin for Acoustic Research. J. Acoust. Soc. Am., vol. 58, No. 1, (Jul. 1975), pp. 214-222.
Camacho-Lopez, et al. Fast Liquid Crystal Elastomer Swims Into the Dark, Electronic Liquid Crystal Communications. Nov. 26, 2003; 9 pages total.
Carlile, et al. Frequency bandwidth and multi-talker environments. Audio Engineering Society Convention 120. Audio Engineering Society, May 20-23, 2006. Paris, France. 118: 8 pages.
Carlile, et al. Spatialisation of talkers and the segregation of concurrent speech. Abstract 1264 (Feb. 24, 2004) from www.aro.org/abstracts/abstracts.html.
Cheng, et al. A Silicon Microspeaker for Hearing Instruments. Journal of Micromechanics and Microengineering 2004; 14(7):859-866.
Co-pending U.S. Appl. No. 17/066,341, inventors Larkin; Brendan et al., filed Oct. 8, 2020.
Co-pending U.S. Appl. No. 17/066,345, inventors Fitz; Kelly et al., filed Oct. 8, 2020.
Dictionary.com's (via American Heritage Medical Dictionary) online dictionary definition of ‘percutaneous’. Accessed on Jun. 3, 2013. 2 pages.
Merriam-Webster's online dictionary definition of ‘percutaneous’. Accessed on Jun. 3, 2013. 3 pages.
Datskos, et al. Photoinduced and thermal stress in silicon microcantilevers. Applied Physics Letters. Oct. 19, 1998; 73(16):2319-2321.
Decraemer, et al. A method for determining three-dimensional vibration in the ear. Hearing Res., 77:19-37 (1994).
Dundas et al. The Earlens Light-Driven Hearing Aid: Top 10 questions and answers. Hearing Review. 2018;25(2):36-39.
Ear. Downloaded from the Internet. Accessed Jun. 17, 2008. 4 pages. URL: http://wwwmgs.bionet.nsc.ru/mgs/gnw/trrd/thesaurus/Se/ear.html.
Edinger, J.R. High-Quality Audio Amplifier With Automatic Bias Control. Audio Engineering; Jun. 1947; pp. 7-9.
Fay. Cat eardrum mechanics. Ph.D. thesis. Disseration submitted to Department of Aeronautics and Astronautics. Standford University. May 2001; 210 pages total.
Fay, et al. Cat eardrum response mechanics. Mechanics and Computation Division. Department of Mechanical Engineering. Standford University. 2002; 10 pages total.
Fay, et al. Preliminary evaluation of a light-based contact hearing device for the hearing impaired. Otol Neurotol. Jul. 2013;34(5):912-21. doi: 10.1097/MAO.0b013e31827de4b1.
Fay, et al. The discordant eardrum, PNAS, Dec. 26, 2006, vol. 103, No. 52, p. 19743-19748.
Fletcher. Effects of Distortion on the Individual Speech Sounds. Chapter 18, ASA Edition of Speech and Hearing in Communication, Acoust Soc.of Am. (republished in 1995) pp. 415-423.
Freyman, et al. Spatial Release from Informational Masking in Speech Recognition. J. Acost. Soc. Am., vol. 109, No. 5, pt. 1, (May 2001); 2112-2122.
Freyman, et al. The Role of Perceived Spatial Separation in the Unmasking of Speech. J. Acoust. Soc. Am., vol. 106, No. 6, (Dec. 1999); 3578-3588.
Fritsch, et al. EarLens transducer behavior in high-field strength MRI scanners. Otolaryngol Head Neck Surg. Mar. 2009;140(3):426-8. doi: 10.1016/j.otohns.2008.10.016.
Galbraith et al. A wide-band efficient inductive transdermal power and data link with coupling insensitive gain IEEE Trans Biomed Eng. Apr. 1987;34(4):265-75.
Gantz, et al. Broad Spectrum Amplification with a Light Driven Hearing System. Combined Otolaryngology Spring Meetings, 2016 (Chicago).
Gantz, et al. Light Driven Hearing System: A Multi-Center Clinical Study. Association for Research in Otolaryngology Annual Meeting, 2016 (San Diego).
Gantz, et al. Light-Driven Contact Hearing Aid for Broad Spectrum Amplification: Safety and Effectiveness Pivotal Study. Otology & Neurotology Journal, 2016 (in review).
Gantz, et al. Light-Driven Contact Hearing Aid for Broad-Spectrum Amplification: Safety and Effectiveness Pivotal Study. Otology & Neurotology. Copyright 2016. 7 pages.
Ge, et al., Carbon nanotube-based synthetic gecko tapes, p. 10792-10795, PNAS, Jun. 26, 2007, vol. 104, No. 26.
Gennum. GA3280 Preliminary Data Sheet: Voyageur TD Open Platform DSP System for Ultra Low Power Audio Processing. Oct. 2006; 17 pages. Downloaded from the Internet: http://www.sounddesigntechnologies.com/products/pdf/37601DOC.pdf.
Gobin, et al. Comments on the physical basis of the active materials concept. Proc. SPIE 2003; 4512:84-92.
Gorb, et al. Structural Design and Biomechanics of Friction-Based Releasable Attachment Devices in Insects. Integr Comp Biol. Dec. 2002. 42(6):1127-1139. doi: 10.1093/icb/42.6.1127.
Hakansson, et al. Percutaneous vs. transcutaneous transducers for hearing by direct bone conduction (Abstract). Otolaryngol Head Neck Surg. Apr. 1990;102(4):339-44.
Hato, et al. Three-dimensional stapes footplate motion in human temporal bones. Audiol. Neurootol., 8:140-152 (Jan. 30, 2003).
Headphones. Wikipedia Entry. Downloaded from the Internet. Accessed Oct. 27, 2008. 7 pages. URL: http://en.wikipedia.org/wiki/Headphones>.
Hofman, et al. Relearning Sound Localization With New Ears. Nature Neuroscience, vol. 1, No. 5, (Sep. 1998); 417-421.
Izzo, et al. Laser Stimulation of Auditory Neurons: Effect of Shorter Pulse Duration and Penetration Depth. Biophys J. Apr. 15, 2008;94(8):3159-3166.
Izzo, et al. Laser Stimulation of the Auditory Nerve. Lasers Surg Med. Sep. 2006;38(8):745-753.
Izzo, et al. Selectivity of Neural Stimulation in the Auditory System: A Comparison of Optic and Electric Stimuli. J Biomed Opt. Mar.-Apr. 2007;12(2):021008.
Jackson, et al. Multiphoton and Transmission Electron Microscopy of Collagen in Ex Vivo Tympanic Membranes. Ninth Annual Symposium on Biomedical Computation at Stanford (BCATS). BCATS 2008 Abstract Book. Poster 18:56. Oct. 2008. URL: http://www.stanford.edu/˜puria1/BCATS08.html.
Jian, et al. A 0.6 V, 1.66 mW energy harvester and audio driver for tympanic membrane transducer with wirelessly optical signal and power transfer. InCircuits and Systems (ISCAS), 2014 IEEE International Symposium on Jun. 1, 2014. 874-7. IEEE.
Jin, et al. Speech Localization. J. Audio Eng. Soc. convention paper, presented at the AES 112th Convention, Munich, Germany, May 10-13, 2002, 13 pages total.
Khaleghi, et al. Attenuating the ear canal feedback pressure of a laser-driven hearing aid. J Acoust Soc Am. Mar. 2017;141(3):1683.
Khaleghi, et al. Attenuating the feedback pressure of a light-activated hearing device to allows microphone placement at the ear canal entrance. IHCON 2016, International Hearing Aid Research Conference, Tahoe City, CA, Aug. 2016.
Khaleghi, et al. Characterization of Ear-Canal Feedback Pressure due to Umbo-Drive Forces: Finite-Element vs. Circuit Models. ARO Midwinter Meeting 2016, (San Diego).
Khaleghi, et al. Mechano-Electro-Magnetic Finite Element Model of a Balanced Armature Transducer for a Contact Hearing Aid. Proc. MoH 2017, Mechanics of Hearing workshop, Brock University, Jun. 2017.
Khaleghi, et al. Multiphysics Finite Element Model of a Balanced Armature Transducer used in a Contact Hearing Device. ARO 2017, 40th ARO MidWinter Meeting, Baltimore, MD, Feb. 2017.
Kiessling, et al. Occlusion Effect of Earmolds with Different Venting Systems. J Am Acad Audiol. Apr. 2005;16(4):237-49.
Killion, et al. The case of the missing dots: AI and SNR loss. The Hearing Journal, 1998. 51(5), 32-47.
Killion. Myths About Hearing in Noise and Directional Microphones. The Hearing Review. Feb. 2004; 11(2):14, 16, 18, 19, 72 & 73.
Killion. SNR loss: I can hear what people say but I can't understand them. The Hearing Review, 1997; 4(12):8-14.
Knight, D. Diode detectors for RF measurement. Paper. Jan. 1, 2016. [Retrieved from Jan. 2016 online] (retrieved Feb. 11, 2020) abstract, p. 1; section 1, p. 6; section 1.3, p. 9; section 3 voltage-double rectifier, p. 21; section 5, p. 27. URL: g3ynh.info/circuits/Diode_det.pdf.
Lee, et al. A Novel Opto-Electromagnetic Actuator Coupled to the tympanic Membrane. J Biomech. Dec. 5, 2008;41(16):3515-8. Epub Nov. 7, 2008.
Lee, et al. The optimal magnetic force for a novel actuator coupled to the tympanic membrane: a finite element analysis. Biomedical engineering: applications, basis and communications. 2007; 19(3):171-177.
Levy, et al. Characterization of the available feedback gain margin at two device microphone locations, in the fossa triangularis and Behind the Ear, for the light-based contact hearing device. Acoustical Society of America (ASA) meeting, 2013 (San Francisco).
Levy, et al. Extended High-Frequency Bandwidth Improves Speech Reception in the Presence of Spatially Separated Masking Speech. Ear Hear. Sep.-Oct. 2015;36(5):e214-24. doi: 10.1097/AUD.0000000000000161.
Levy et al. Light-driven contact hearing aid: a removable direct-drive hearing device option for mild to severe sensorineural hearing impairment. Conference on Implantable Auditory Prostheses, Tahoe City, CA, Jul. 2017. 4 pages.
Lezal. Chalcogenide glasses—survey and progress. Journal of Optoelectronics and Advanced Materials. Mar. 2003; 5(1):23-34.
Mah. Fundamentals of photovoltaic materials. National Solar Power Research Institute. Dec. 21, 1998, 3-9.
Makino, et al. Epithelial migration in the healing process of tympanic membrane perforations. Eur Arch Otorhinolaryngol. 1990; 247: 352-355.
Makino, et al., Epithelial migration on the tympanic membrane and external canal, Arch Otorhinolaryngol (1986) 243:39-42.
Markoff. Intuition + Money: An Aha Moment. New York Times Oct. 11, 2008, p. BU4, 3 pages total.
Martin, et al. Utility of Monaural Spectral Cues is Enhanced in the Presence of Cues to Sound-Source Lateral Angle. JARO. 2004; 5:80-89.
McElveen et al. Overcoming High-Frequency Limitations of Air Conduction Hearing Devices Using a Light-Driven Contact Hearing Aid. Poster presentation at The Triological Society, 120th Annual Meeting at COSM, Apr. 28, 2017; San Diego, CA.
Michaels, et al., Auditory epithelial migration on the human tympanic membrane: II. The existence of two discrete migratory pathways and their embryologic correlates. Am J Anat. Nov. 1990. 189(3):189-200. DOI: 10.1002/aja.1001890302.
Moore, et al. Perceived naturalness of spectrally distorted speech and music. J Acoust Soc Am. Jul. 2003;114(1):408-19.
Moore, et al. Spectro-temporal characteristics of speech at high frequencies, and the potential for restoration of audibility to people with mild-to-moderate hearing loss. Ear Hear. Dec. 2008;29(6):907-22. doi: 10.1097/AUD.0b013e31818246f6.
Moore. Loudness perception and intensity resolution. Cochlear Hearing Loss, Chapter 4, pp. 90-115, Whurr Publishers Ltd., London (1998).
Murphy, et al. Adhesion and anisotropic friction enhancements of angled heterogeneous micro-fiber arrays with spherical and spatula tips. Journal of Adhesion Science and Technology. vol. 21. No. 12-13. Aug. 2007. pp. 1281-1296. DOI: 10.1163/156856107782328380.
Murugasu, et al. Malleus-to-footplate versus malleus-to-stapes-head ossicular reconstruction prostheses: temporal bone pressure gain measurements and clinical audiological data. Otol Neurotol. Jul. 2005;26(4):572-82. DOI: 10.1097/01.mao.0000178151.44505.1b.
Musicant, et al. Direction-dependent spectral properties of cat external ear: new data and cross-species comparisons. J Acoust Soc Am. Feb. 1990. 87(2):757-781. DOI: 10.1121/1.399545.
National Semiconductor. LM4673 Boomer: Filterless, 2.65W, Mono, Class D Audio Power Amplifier. Nov. 1, 2007. 24 pages. [Data Sheet] downloaded from the Internet: URL: http://www.national.com/ds/LM/LM4673.pdf.
Nishihara, et al. Effect of changes in mass on middle ear function. Otolaryngol Head Neck Surg. Nov. 1993;109(5):889-910.
O'Connor, et al. Middle ear Cavity and Ear Canal Pressure-Driven Stapes Velocity Responses in Human Cadaveric Temporal Bones. J Acoust Soc Am. Sep. 2006;120(3):1517-28.
Park, et al. Design and analysis of a microelectromagnetic vibration transducer used as an implantable middle ear hearing aid. J. Micromech. Microeng. vol. 12 (2002), pp. 505-511.
Perkins, et al. Light-based Contact Hearing Device: Characterization of available Feedback Gain Margin at two device microphone locations. Presented at AAO-HNSF Annual Meeting, 2013 (Vancouver).
Perkins, et al. The EarLens Photonic Transducer: Extended bandwidth. Presented at AAO-HNSF Annual Meeting, 2011 (San Francisco).
Perkins, et al. The EarLens System: New sound transduction methods. Hear Res. Feb. 2, 2010; 10 pages total.
Perkins, R. Earlens tympanic contact transducer: a new method of sound transduction to the human ear. Otolaryngol Head Neck Surg. Jun. 1996;114(6):720-8.
Poosanaas, et al. Influence of sample thickness on the performance of photostrictive ceramics, J. App. Phys. Aug. 1, 1998; 84(3):1508-1512.
Puria et al. A gear in the middle ear. ARO Denver CO, 2007b.
Puria, et al. Cues above 4 kilohertz can improve spatially separated speech recognition. The Journal of the Acoustical Society of America, 2011, 129, 2384.
Puria, et al. Extending bandwidth above 4 kHz improves speech understanding in the presence of masking speech. Association for Research in Otolaryngology Annual Meeting, 2012 (San Diego).
Puria, et al. Extending bandwidth provides the brain what it needs to improve hearing in noise. First international conference on cognitive hearing science for communication, 2011 (Linkoping, Sweden).
Puria, et al. Hearing Restoration: Improved Multi-talker Speech Understanding. 5th International Symposium on Middle Ear Mechanics in Research and Otology (MEMRO), Jun. 2009 (Stanford University).
Puria, et al. Imaging, Physiology and Biomechanics of the middle ear: Towards understating the functional consequences of anatomy. Stanford Mechanics and Computation Symposium, 2005, ed Fong J.
Puria, et al. Malleus-to-footplate ossicular reconstruction prosthesis positioning: cochleovestibular pressure optimization. Otol Nerotol. May 2005; 26(3):368-379. DOI: 10.1097/01.mao.0000169788.07460.4a.
Puria, et al. Measurements and model of the cat middle ear: Evidence of tympanic membrane acoustic delay. J. Acoust. Soc. Am., 104(6):3463-3481 (Dec. 1998).
Puria, et al., Mechano-Acoustical Transformations in A. Basbaum et al., eds., The Senses: A Comprehensive Reference, v3, p. 165-201, Academic Press (2008).
Puria, et al. Middle Ear Morphometry From Cadaveric Temporal Bone MicroCT Imaging. Proceedings of the 4th International Symposium, Zurich, Switzerland, Jul. 27-30, 2006, Middle Ear Mechanics in Research and Otology, pp. 260-269.
Puria, et al. Sound-Pressure Measurements in the Cochlear Vestibule of Human-Cadaver Ears. Journal of the Acoustical Society of America. 1997; 101 (5-1): 2754-2770.
Puria, et al. Temporal-Bone Measurements of the Maximum Equivalent Pressure Output and Maximum Stable Gain of a Light-Driven Hearing System That Mechanically Stimulates the Umbo. Otol Neurotol. Feb. 2016;37(2):160-6. doi: 10.1097/MAO.0000000000000941.
Puria, et al. The EarLens Photonic Hearing Aid. Association for Research in Otolaryngology Annual Meeting, 2012 (San Diego).
Puria, et al. The Effects of bandwidth and microphone location on understanding of masked speech by normal-hearing and hearing-impaired listeners. International Conference for Hearing Aid Research (IHCON) meeting, 2012 (Tahoe City).
Puria, et al. Tympanic-membrane and malleus-incus-complex co-adaptations for high-frequency hearing in mammals. Hear Res. May 2010;263(1-2):183-90. doi: 10.1016/j.heares.2009.10.013. Epub Oct. 28, 2009.
Puria. Measurements of human middle ear forward and reverse acoustics: implications for otoacoustic emissions. J Acoust Soc Am. May 2003;113(5):2773-89.
Puria, S. Middle Ear Hearing Devices. Chapter 10. Part of the series Springer Handbook of Auditory Research pp. 273-308. Date: Feb. 9, 2013.
Qu, et al. Carbon nanotube arrays with strong shear binding-on and easy normal lifting-off. Science. Oct. 10, 2008. 322(5899):238-342. doi: 10.1126/science.1159503.
Robles, et al. Mechanics of the mammalian cochlea. Physiol Rev. Jul. 2001;81(3):1305-52.
Roush. SiOnyx Brings “Black Silicon” into the Light; Material Could Upend Solar, Imaging Industries. Xconomy, Oct. 12, 2008, retrieved from the Internet: www.xconomy.com/boston/2008/10/12/sionyx-brings-black-silicon-into-the-light¬material-could-upend-solar-imaging-industries 4 pages total.
Rubinstein. How cochlear implants encode speech. Curr Opin Otolaryngol Head Neck Surg. Oct. 2004. 12(5):444-448. DOI: 10.1097/01.moo.0000134452.24819.c0.
School of Physics Sydney, Australia. Acoustic Compliance, Inertance and Impedance. 1-6. (2018). http://www.animations.physics.unsw.edu.au/jw/compliance-inertance-impedance.htm.
Sekaric, et al. Nanomechanical resonant structures as tunable passive modulators. Applied Physics Letters. May 2002. 80(19):3617-3619. DOI: 10.1063/1.1479209.
Shaw. Transformation of Sound Pressure Level From the Free Field to the Eardrum in the Horizontal Plane. J. Acoust. Soc. Am., vol. 56, No. 6, (Dec. 1974), 1848-1861.
Shih, et al. Shape and displacement control of beams with various boundary conditions via photostrictive optical actuators. Proc. IMECE. Nov. 2003; 1-10.
Smith. The Scientist and Engineers Guide to Digital Signal Processing. California Technical Publishing. 1997. Chapter 22. pp. 351-372.
Song, et al. The development of a non-surgical direct drive hearing device with a wireless actuator coupled to the tympanic membrane. Applied Acoustics. Dec. 31, 2013;74(12):1511-8.
Sound Design Technologies. Voyager TD Open Platform DSP System for Ultra Low Power Audio Processing—GA3280 Data Sheet. Oct. 2007. 15 pages. Retrieved from the Internet: http://www.sounddes.com/pdf/37601DOC.pdf.
Spolenak, et al. Effects of contact shape on the scaling of biological attachments. Proc. R. Soc. A. 2005; 461:305-319.
Stenfelt, et al. Bone-Conducted Sound: Physiological and Clinical Aspects. Otology & Neurotology, Nov. 2005; 26 (6):1245-1261.
Struck, et al. Comparison of Real-world Bandwidth in Hearing Aids vs Earlens Light-driven Hearing Aid System. The Hearing Review. TechTopic: EarLens. Hearingreview.com. Mar. 14, 2017. pp. 24-28.
Stuchlik, et al. Micro-Nano Actuators Driven by Polarized Light. IEEE Proc. Sci. Meas. Techn. Mar. 2004; 151(2):131-136.
Suski, et al. Optically activated ZnO/SiO2/Si cantilever beams. Sensors and Actuators A: Physical. Sep. 1990. 24(3): 221-225. https://doi.org/10.1016/0924-4247(90)80062-A.
Takagi, et al. Mechanochemical Synthesis of Piezoelectric PLZT Powder. KONA. 2003; 51(21):234-241.
Thakoor, et al. Optical microactuation in piezoceramics. Proc. SPIE. Jul. 1998; 3328:376-391.
Thompson. Tutorial on microphone technologies for directional hearing aids. Hearing Journal. Nov. 2003; 56(11):14-16,18, 20-21.
Tzou, et al. Smart Materials, Precision Sensors/Actuators, Smart Structures, and Structronic Systems. Mechanics of Advanced Materials and Structures. 2004; 11:367-393.
Uchino, et al. Photostricitve actuators. Ferroelectrics. 2001; 258:147-158.
Vickers, et al. Effects of Low-Pass Filtering on the Intelligibility of Speech in Quiet for People With and Without Dead Regions at High Frequencies. J. Acoust. Soc. Am. Aug. 2001; 110(2):1164-1175.
Vinge. Wireless Energy Transfer by Resonant Inductive Coupling. Master of Science Thesis. Chalmers University of Technology. 1-83 (2015).
Vinikman-Pinhasi, et al. Piezoelectric and Piezooptic Effects in Porous Silicon. Applied Physics Letters, Mar. 2006; 88(11): 111905-1-111905-2. DOI: 10.1063/1.2186395.
Wang, et al. Preliminary Assessment of Remote Photoelectric Excitation of an Actuator for a Hearing Implant. Proceeding of the 2005 IEEE, Engineering in Medicine and Biology 27th nnual Conference, Shanghai, China. Sep. 1-4, 2005; 6233-6234.
Web Books Publishing, “The Ear,” accessed online Jan. 22, 2013, available online Nov. 2, 2007 at http://www.web-books.com/eLibrary/Medicine/Physiology/Ear/Ear.htm.
Wiener, et al. On the Sound Pressure Transformation By the Head and Auditory Meatus of the Cat. Acta Otolaryngol. Mar. 1966; 61(3):255-269.
Wightman, et al. Monaural Sound Localization Revisited. J Acoust Soc Am. Feb. 1997;101(2):1050-1063.
Wiki. Sliding Bias Variant 1, Dynamic Hearing (2015).
Wikipedia. Inductive Coupling. 1-2 (Jan. 11, 2018). https://en.wikipedia.org/wiki/Inductive_coupling.
Wikipedia. Pulse-density Coupling. 1-4 (Apr. 6, 2017). https://en.wikipedia.org/wiki/Pulse-density_modulation.
Wikipedia. Resonant Inductive Coupling. 1-11 (Jan. 12, 2018). https://en.wikipedia.org/wiki/Resonant_inductive_coupling#cite_note-13.
Yao, et al. Adhesion and sliding response of a biologically inspired fibrillar surface: experimental observations, J. R. Soc. Interface (2008) 5, 723-733 doi:10.1098/rsif.2007.1225 Published online Oct. 30, 2007.
Yao, et al. Maximum strength for intermolecular adhesion of nanospheres at an optimal size. J R Soc Interface. Nov. 6, 2008;5(28):1363-70. doi: 10.1098/rsif.2008.0066.
Yi, et al. Piezoelectric Microspeaker with Compressive Nitride Diaphragm. The Fifteenth IEEE International Conference on Micro Electro Mechanical Systems, 2002; 260-263.
Yu, et al. Photomechanics: Directed bending of a polymer film by light. Nature. Sep. 11, 2003;425(6954):145. DOI: 10.1038/425145a.
Co-pending U.S. Appl. No. 17/356,217, inventors Imatani; Kyle et al., filed Jun. 23, 2021.
Co-pending U.S. Appl. No. 17/412,850, inventors Flaherty; Bryan et al., filed Aug. 26, 2021.
Folkeard, et al. Detection, Speech Recognition, Loudness, and Preference Outcomes With a Direct Drive Hearing Aid: Effects of Bandwidth. Trends Hear. Jan.-Dec. 2021; 25: 1-17. doi: 10.1177/2331216521999139.
PCT/US2019/020942 International Search Report and Written Opinion dated May 31, 2019.
Co-pending U.S. Appl. No. 17/549,722, inventor Rucker; Paul, filed Dec. 13, 2021.
Related Publications (1)
Number Date Country
20200396551 A1 Dec 2020 US
Provisional Applications (1)
Number Date Country
62639796 Mar 2018 US
Continuations (1)
Number Date Country
Parent PCT/US2019/020942 Mar 2019 US
Child 17007800 US